Skip to main content
PLOS Genetics logoLink to PLOS Genetics
. 2026 Feb 13;22(2):e1011740. doi: 10.1371/journal.pgen.1011740

PIKI-1, a class II PI 3-kinase, functions in endocytic trafficking

Gabrielle R Reimann 1, Philip T Edeen 1, Sylvia Conquest 1, Barth D Grant 2, David S Fay 1,*
Editor: Nathalie Pujol3
PMCID: PMC12919929  PMID: 41686813

Abstract

Cellular membrane trafficking, including endocytosis and exocytosis, is a complex process coordinated by trafficking-associated proteins, cargo molecules, the cytoskeleton, and membrane lipids. The NIMA-related kinases NEKL-2 (human NEK8/9) and NEKL-3 (human NEK6/7) are conserved regulators of membrane trafficking in Caenorhabditis elegans that are required for the completion of molting. Using a genetic approach, we isolated reduction-of-function mutations in piki-1 that suppress nekl-associated molting defects. piki-1 encodes the sole predicted C. elegans Class II PI 3-kinase (PI3K), a relatively understudied class of lipid modifiers that contribute to the production of PI 3-phosphate (PI(3)P) and PI 3,4-bisphosphate (PI(3,4)P2). Using genetically encoded lipid sensors, we found that PIKI-1 was responsible for the production of PI(3,4)P2 in the C. elegans epidermis but played only a minor role in contributing to PI(3)P levels. Consistent with this, both PI(3,4)P2 and PIKI-1 partially colocalized to early endosomes, and reduction of PIKI-1 affected the size and protein composition of early endosomal compartments marked by RAB-5, EEA-1, and SNX-1. Reduced PIKI-1 also led to increased tubulation of endosomal compartments associated with recycling or the degradation of cellular debris. In contrast to studies using mammalian cell culture, PIKI-1 was largely dispensable for clathrin-mediated endocytosis in the worm epidermis, a polarized epithelium. Notably, reduction of PIKI-1 function mitigated defects in early endosomes associated with the depletion of NEKL-2. We propose that reduction of PIKI-1 function may suppress nekl molting defects by partially restoring endocytic trafficking function within a subset of compartments, including the early endosome. We also show that inhibition of HIPR-1, an ortholog of the mammalian PI(3,4)P₂-binding proteins, HIP1 and HIPR1, suppresses nekl molting defects, consistent with a model that loss of PIKI-1 alters the binding of endocytic regulators in a manner that partially compensates for the loss of NEKL-2 activity.

Author summary

The uptake of materials from outside the cell and their subsequent delivery to specific intracellular locations are essential for cell function and survival. Two of the mechanisms that control this complex intracellular pathway involve the modification of proteins and of lipids, processes that are highly conserved across species. In this study, we used the model organism Caenorhabditis elegans, which is highly amenable to cell biological and genetic approaches, to establish a novel connection between these two regulatory mechanisms and demonstrate the importance of lipid modifications in maintaining the normal functioning of intracellular transport. Our results also provide insights into the fundamental cellular functions of proteins associated with human disease including cancer and metabolic disease.

Introduction

Polyphosphoinositides (PPIns) are a family of small phospholipids embedded in the cytosolic leaflet of the plasma membrane and membrane-bound organelles [14]. PPIns are derived from the membrane lipid phosphatidylinositol (PI), which consists of a glycerol backbone esterified to two fatty acid chains and a phosphate group that links to a polar myo-inositol head group projecting into the cytoplasm (Fig 1A). Modification of the myo-inositol head group at hydroxyl positions 3’, 4’, and 5’ can lead to the production of seven different PPIns species (Fig 1B). Interconversion of PI and PPIns species is controlled by several classes of PI kinases and phosphatases (Fig 1B) [5]. The interconnected nature of the PPIns pathway and the ability of PPIns to undergo reversible modifications allows for tight spatiotemporal control of PPIns on cellular membranes [57]. Correspondingly, the concentration of specific PPIns on cytosolic leaflets controls the recruitment of membrane trafficking and signaling proteins, thereby impacting fundamental cellular processes [47]. Although crucial for regulation, PPIns are a low abundance lipid species; PI makes up ~10% of the total membrane phospholipid pool whereas PPIns are estimated to comprise only 0.2–1% and are comparatively short-lived [2,8,9].

Fig 1. nekl-associated molting defects are suppressed by loss of function of piki-1.

Fig 1

(A) Graphical representation of a phosphatidylinositol (PI). The 3’ position in the inositol ring that is phosphorylated by PI 3-kinases (PI3Ks) is indicated by the green arrow. (B) Schematic diagram of the PPIns biosynthesis pathway. Dark gray arrows represent lipid kinase activity; light gray arrows indicate lipid phosphatase activity. The reactions catalyzed by the different classes of PI3Ks are indicated. Green arrows indicate reactions catalyzed by class II PI3Ks. C. elegans genes coding for kinases and phosphatases are listed by the reaction they are predicted catalyze; essential genes are in red text. (C) Merged DIC and fluorescence image of a representative nekl-2(fd81); nekl-3(gk894345) worm carrying an extrachromosomal rescuing array (fdEx286) containing wild-type nekl-3 and a broadly expressed reporter (SUR-5::GFP). (D) DIC image of an L2/L3 arrested nekl-2(fd81); nekl-3(gk894345) larva that failed to inherit fdEx286. White arrows indicate boundaries where the old cuticle has been shed from the head and tail but not from the midbody. (E) Representative DIC image of a suppressed nekl-2(fd81); nekl-3(gk8942345); piki-1(fd161) mutant, which does not require fdEx286 for viability. (F) Percentages of viable adults for the indicated genotypes; corresponding amino acid changes are indicated in parentheses next to the piki-1 allele designation. The number of animals analyzed per genotype is indicated in the graph. Data are shown as the mean and 95% confidence interval (CI). Statistical significance was determined using Fischer’s exact test; ****p ≤ 0.0001 relative to control (WY1145). Raw data are available in S1 File. (G) Schematic diagram of the piki-1 gene; black rectangles denote exons and lines denote introns. The locations of missense alleles are indicated by arrows. The large deletion (Δ) ok2346 is indicated by a line beneath the affected exons and introns. (H) Schematic diagram of the PIKI-1 protein showing predicted domains; red arrowheads indicate known motifs. Black arrows indicate the positions of amino acids altered in piki-1 mutants; black line indicates the region affected by the ok2346 deletion. C2A, first C2 domain; C2B, second C2 domain; [NLS, nuclear localization signal;] PIK, PI3K class II accessory domain; PX, phox homology domain; RBD, Ras-binding domain.

One family of lipid modifiers, phosphatidylinositol 3-kinases (PI3Ks), specifically phosphorylate the hydroxyl group at position 3’ on the inositol ring to produce three different PPIns species; PI (3,4,5)-trisphosphate [PI(3,4,5)P3], PI 3,4-bisphosphate [PI(3,4)P2], and PI 3-phosphate [PI(3)P] (s 1B) [1012]. PI3Ks are subdivided into three classes, based on the PPIns species they produce, their protein domains, and their interactions with different regulatory subunits [1214]. Class I PI3Ks produce PI(3,4,5)P3 from PI(4,5)P2 and are involved in pathways that regulate cell growth, proliferation, metabolism, and autophagy [1517]. Class III PI3Ks produce PI(3)P from PI and primarily regulate membrane trafficking, including endosome-to-lysosome maturation and autophagy [16,18]. Class II PI3Ks can produce PI(3)P from PI as well as PI(3,4)P2 from PI(4)P and are less well characterized than Class I or III PI3Ks (Fig 1B) [1921]. This is due in part to the partial functional overlap of Class II PI3Ks with both Class I and III enzymes [12,14,16,22]. For example, both Class II and Class III enzymes can produce PI(3)P [7,19,21,2325], and PI(3,4)P2 can be generated by the 5’ dephosphorylation of the Class I PI3K product, PI(3,4,5)P3 (Fig 1B) [2631]. Class II PI3Ks also differ from Class I and III enzymes in that they are not known to form stable complexes with regulatory units [20,21,3236]. The regulatory subunits of Class I and III PI3Ks have been shown to control the localization and activity of these kinases whereas the regulation of Class II PI3Ks is less well understood. Finally, the connection of Class II PI3Ks to human disease is less well established than for class I and III enzymes [11,37,38].

The role of PI3Ks and their products is crucial for multiple steps in membrane trafficking [2,3,39]. For example, uptake of cargo by clathrin-mediated endocytosis is dependent on PI 4,5-bisphosphate [PI(4,5)P2], which is required for initiating formation of the clathrin lattice on budding vesicles [4045]. During maturation of the clathrin-coated pit, other PI3Ks and lipid phosphatases are subsequently recruited to modify the PPIns population, which is necessary for the recruitment of proteins that promote vesicle scission and the internalization of cargo [46]. After internalization, nascent vesicles fuse with the early endosome (also referred to as the sorting endosome), where cargo is sorted for delivery to specific intracellular locations [47,48]. Within the early endosome, the PPIns population consists primarily of PI(3)P, produced by class III PI3Ks with some contribution from class II PI3Ks [49,50]. Here, PI(3)P recruits early endosome effectors necessary for vesicular docking, fusion, and the subsequent sorting of cargo [7,4952]. During maturation of the early endosome additional subdomains develop, a process that is driven by cargo, membrane-associated proteins, and underlying changes in the composition of the PPIns [49]. For example, PI(3,5)P2 affects the sorting of proteins destined for late endosomes and degradation in the lysosome [49,53,54]. The production of PI(3,4)P2 on early endosome subdomains has been proposed to play a role in recruiting and activating Rab11 and directing the transport of cargo to recycling pathways [55,56]. PI(3,4)P2 has also been implicated in the recruitment of proteins that promote vesicle remodeling and scission [6,29,38,48,5759]. However, the principle means by which PI(3,4)P2 is produced at these membranes is unclear, although there is evidence that PI(3,4)P2 can be synthesized directly by class II PI3Ks and is not derived solely from the dephosphorylation of PI(3,4,5)P3 [26,27,29,31,57,58,60,61].

Some challenges inherent to studying the roles of PI3Ks and other PI/PPIns modifiers include the transient nature of PPIns species, the interdependency of pathway modifiers and substrates, and the ability to generate identical PPIns through more than one route [6264]. Such features can complicate the interpretation of genetic perturbations or the use of selective inhibitors, and highly selective inhibitors are not available for all enzymes including class II PI3Ks. [18,32,65]. Another challenge is posed by the heterogeneous and dynamic nature the endosomal compartments marked by PPIns, which can consist of multiple subpopulations and often contain differentially marked subdomains on their cytosolic surfaces [48,66,67]. Finally, the ability to visualize PPIns inside cells using antibodies has not been widely adopted because the fixation methods required preclude live imaging, which is invaluable for determining the localization, dynamics, and functions of these small lipids [62,68]. This last challenge has been addressed by the development of genetically encoded lipid biosensors, which tether fluorescent proteins to lipid-binding domains that can recognize individual PPIns species [6971]. Nevertheless, the use of lipid biosensors is complicated by their cross-specificity with different lipids, by difficulties with matching sensor levels to the abundance of the PPIns species, and by adverse physiological effects caused by the sensors, which may compete with native PPIns-binding proteins for limited sites [62,6971]. Despite these complications, lipid biosensors are currently the best tool available for visualizing intracellular PPIns pools and understanding their roles in membrane trafficking.

In this study we use the nematode, Caenorhabditis elegans, as an established model for studying membrane trafficking within a live intact organism [72]. Membrane trafficking is closely coupled to the C. elegans molting cycle, as the inhibition of trafficking proteins can lead to strong defects in the molting process [73]. Previously, we have shown that two conserved NIMA-related Ser/Thr protein kinases, NEKL-2 (NEK8/9 in mammals) and NEKL-3 (NEK6/7), and their binding partners, the conserved ankyrin repeat proteins MLT-2, MLT-3, and MLT-4 (mammalian ANKS6, ANKS3, and INVS, respectively), are essential for proper molting, in large part through their roles in controlling membrane trafficking [7478]. We also described a genetic approach for identifying suppressors of nekl-associated molting defects, which led to the identification of several conserved regulators of membrane trafficking, including TAT-1 (mammalian ATP8A1/2), a phosphatidylserine flippase, along with components and regulators of clathrin mediated endocytosis [75,79].

Here we report the identification of mutations affecting PIKI-1, a C. elegans ortholog of mammalian class II PI3Ks, which comprise three family members (PI3KC2A, PI3KC2B, PI3KC2G) [10,12,16,21]. Importantly, PIKI-1 is the sole predicted class II PI3K in C. elegans, allowing us to study class II PI3K functions in the absence of genetic redundancy caused by paralogs. We found that reduction of PIKI-1 activity led to defects in several endocytic compartments, most notably the early endosome. To better understand the cellular functions of PIKI-1, we generated PPIns biosensors to visualize lipid pools in the epidermis of adult worms. Our study indicated that whereas PIKI-1 is a minor contributor to PI(3)P pools in the epidermis, it is a major contributor to PI(3,4)P2 levels, supporting the model that PI(3,4)P2 is predominantly synthesized by class II PI3Ks and not through the degradation of class I PI3K–derived products. We also provide evidence that loss of piki-1 can alleviate defects caused by loss of NEKL-2 function at early endosomes, suggesting a mechanism by which piki-1 mutations may suppress nekl–associated molting defects.

Results

nekl reduction-of-function molting defects are suppressed by mutations in piki-1

We previously described a forward genetic screen and whole-genome sequencing pipeline to identify genetic suppressors of larval lethality caused by nekl reduction-of-function mutations [80]. Briefly, this approach exploits a synthetic lethal interaction that occurs when two aphenotypic (weak) reduction-of-function alleles of nekl-2(fd81) and nekl-3(gk894345) are combined in the same animal. nekl-2(fd81); nekl-3(gk894345) (hereafter nekl-2; nekl-3) worms showed highly penetrant molting defects, with ~98% of progeny arresting at the L2/L3 boundary and only ~2% progressing to adulthood (Fig 1D and 1F). nekl-2; nekl-3 worms can be propagated in the presence of a rescuing extrachromosomal array (fdEx286) containing wild-type copies of nekl-3 and a sur-5::GFP reporter to facilitate the visualization of array-positive animals (Fig 1C). Worms failing to inherent the array in the parental strain exhibited a “corset” phenotype, whereby old cuticle failed to be consistently shed from midbody (Fig 1D). Following mutagenesis, worms containing suppressor mutations were identified by their ability to reach adulthood and propagate robustly in the absence of the rescuing array (Fig 1E).

From our suppressor screen, we identified three independent alleles affecting the piki-1 locus (fd161, fd275, and fd357), such that ~50–65% of nekl-2; nekl-3 piki-1 worms reached adulthood (Fig 1F). Two alleles, fd161 and fd357, both cause a C-to-T transition in the second-to-last exon of piki-1, resulting in premature stop codons at amino acids 1507 and 1503, respectively (Fig 1G and 1H). The third allele, fd275, is a G-to-A transition in the fifth exon of piki-1, leading to the substitution of asparagine for serine at amino acid 211 (Fig 1G and 1H). fd161 and fd357 would be expected to remove the terminal C2B domain, which binds PI(4,5)P2 and PI(3,4,5)P3, facilitating membrane localization and likely impacting enzymatic function [81]. fd161 and fd357 may also be subject nonsense-mediated decay, resulting in reduced mRNA and protein levels in addition to truncation of the protein [82]. S211 is in a non-conserved region of PIKI-1 that is predicted to be largely unstructured; its effects on PIKI-1 function are currently unknown.

CRISPR phenocopy of fd161 (fd381) led to levels of suppression that were similar to those observed for fd161 (Fig 1F), demonstrating that piki-1 is the causal locus in the nekl-2; nekl-3 piki-1(fd161) strain. Additionally, fd161 failed to complement fd275, consistent with piki-1 being the causal locus in both strains. Moreover, a consortium-generated 1597-bp deletion mutation [83] in piki-1 (ok2346) led to 66% of nekl-2; nekl-3 piki-1(ok2346) worms reaching adulthood (Fig 1F1H). Using CRISPR, we introduced a mutation into the catalytic domain of PIKI-1 (D1189A) that is expected to strongly reduce PIKI-1 kinase activity [13] and observed ~50% viability of nekl-2; nekl-3 adults, indicating that PIKI-1 enzymatic activity is critical to its function and relevant to its genetic interactions with the nekls. Conversely, we failed to observe robust suppression of nekl-2; nekl-3 defects by piki-1(RNAi) using dsRNA injection methods, which is likely due to insufficient knockdown of piki-1 (4.8% viability; S1A Fig). Finally, piki-1(Q1507Stop) failed to suppress a stronger loss-of-function nekl-2 allele, fd91 (0% viability; n = 139), indicating that piki-1 mutations may suppress only a subset of partial reduction-of-function mutations in the nekls.

PIKI-1 belongs to a family of lipid kinases that specifically phosphorylate the 3’ hydroxyl position on the inositol ring of membrane PIs and PPIns (Fig 1A) [12,16]. More specifically, PIKI-1 is the sole member of the class II PI3Ks in C. elegans, which in other species have been reported to convert PI to PI(3)P and PI(4)P to PI(3,4)P2 (Fig 1B) [1921]. Given the proposed role of PIKI-1 in PI/PPIns modification, we tested several additional (non-essential) PPIns modifiers for genetic interactions with the nekls. Given that PI(3,4)P2 can be derived from PI(3,4,5)P3 after removal of the 5’ phosphate (Fig 1B), we tested AGE-1, the sole class I PI3K in C. elegans and producer of PI(3,4,5)P3 [84,85]. We found that inhibition of age-1 by RNAi (using dsRNA injection methods) or a reduction-of-function mutation (hx546) had little or no ability to suppress molting defects in nekl-2; nekl-3 mutants (S1A and S1B Fig). Likewise, RNAi of inpp-1, a putative 5′ phosphatase predicted to convert PI(3,4,5)P3 to PI(3,4)P2, also failed to promote strong suppression (7.8% viability; S1A Fig). Nevertheless, RNAi of inpp-1 led to a ~ 45% reduction in brood size in the F1 progeny of injected nekl-2; nekl-3 worms (S1 File), indicating that inhibition of INPP-1 by RNAi methods impacts fertility. Collectively, our results suggest that loss of piki-1 may be unique in its ability to robustly suppress nekl defects, although our inability to test essential PPIns modifiers, along with caveats associated with partial knockdown by RNAi, limit these conclusions.

PIKI-1 localizes to clathrin-coated pits and early endosomes

Previously, we reported colocalization of NEKL-2 and NEKL-3 with several internal membrane-bound compartments, consistent with roles for the NEKLs in endocytic trafficking [74]. More specifically, NEKL-2 localizes most extensively to early endosomes, whereas NEKL-3 resides predominantly at late endosomes. Mammalian class II PI3Ks localize to early endosomal compartments and to clathrin-coated structures, as well as to recycling endosomes [21,86,87]. In C. elegans, PIKI-1 localizes to nascent phagosomes in embryos and in the germline [8892].

To characterize the endogenous localization of PIKI-1 in the epidermis, we first examined CRISPR-generated fusions of either GFP or mScarlet to the C terminus of PIKI-1. However, endogenous PIKI-1::GFP proved too dim for reliable imaging (S2A Fig) and PIKI-1::mScarlet showed non-specific localization to lysosomes (S2B Fig), which is likely due to cleavage of the fluorophore and its retention in lysosomes [93]. We note, that PIKI-1::GFP retains at least partial activity as we failed to observe suppression of molting defects in nekl-2; nekl-3 piki-1::GFP worms (0% viability; n = 226). To enable visualization of PIKI-1, we integrated a single-copy PIKI-1::mNeonGreen transgene driven by a promoter expressed predominantly in the hyp7 epidermal syncytium (Phyp7; semo-1) using miniMos methods [94]; semo-1 is expressed at ~10-fold higher levels than piki-1 in young adults [95,96]. Phyp7::PIKI-1::mNeonGreen was expressed in the adult epidermis both diffusely and in punctate structures located near the apical plasma membrane (Fig 2A, 2B, 2B’, 2D and 2D’) as well as in more irregularly shaped structures located apically but below the membrane (Fig 2I and 2I’). Based on the distribution and size of Phyp7::PIKI-1::mNeonGreen puncta, we hypothesized that PIKI-1 may localize to clathrin-coated pits–vesicles and to apical endosomes, consistent with prior studies on mammalian class II PI3Ks.

Fig 2. PIKI-1 colocalizes with clathrin-coated pits and the early endosome.

Fig 2

(A) Schematic diagram of an adult C. elegans as a transverse cross-section (top) and a longitudinal cross-section (bottom), which corresponds to figure panels. The black dashed line on the transverse cross-section denotes the apical plane visualized in the longitudinal cross-section for a single z-slice. Bottom right contains a key indicating the relevant cell types and membranes. (B, B’) Representative unprocessed images of a day-1 adult expressing Phyp7::PIKI-1::mNeonGreen. White arrows indicate apical puncta. (C–E’) Colocalization of day-1 adult worms expressing (C, C’) CRISPR CLIC-1::mScarlet and (D, D’) Phyp7::PIKI-1::mNeonGreen (n = 32); (E, E’) merged images. (H–J’) Trans-heterozygous worms expressing (H, H’) Pdyp-7::mKate2::RAB-5 and (I, I’) Phyp7::PIKI-1::mNeonGreen (n = 23); (J and J’) merged images. The seam cell is labeled in lower-magnification images. Yellow squares (C–E and H–J) indicate the locations of the enlarged insets (C’–E’ and H’–J’). In merged insets (E’, J’), yellow arrows indicate examples of colocalization (white). (F, G, K and L) Colocalization was quantified using Mander’s overlap (F and K) and Pearson’s correlation coefficients (G, L). Dot plots show the mean and 95% CI. Statistical significance between rotated and inset values was determined using unpaired t-tests; ****p ≤ 0.0001. Raw data are available in S1 File.

As anticipated, we observed colocalization between a marker for clathrin light chain, mScarlet::CLIC-1, and PIKI-1::mNeonGreen (Fig 2C2E’). However, whereas ~50% of the mScarlet::CLIC-1 signal overlapped with the PIKI-1::mNeonGreen signal (Manders’ overlap = ~0.5), only ~25% of PIKI-1::mNeonGreen overlapped with mScarlet::CLIC-1 (Manders’ overlap = ~0.25) (Fig 2F), indicating that PIKI-1 localizes to additional membrane compartments. Significant positive but partial overlap between the markers was also supported by the Pearson’s correlation coefficient (PCC = ~0.23) (Fig 2G). As an additional control for all colocalization experiments, we rotated one of the two channels and reanalyzed the Manders’ and Pearson’s values and observed a dramatic reduction in both measurements, indicating that the observed overlap was non-random (Fig 2F and 2G).

We next examined colocalization between PIKI-1::mNeonGreen and a marker for early endosomes, Pdpy-7::mKate2::RAB-5. In animals that were heterozygous for both markers (also see Materials and Methods) we found that ~40% of the mKate2::RAB-5 signal overlapped with PIKI-1::mNeonGreen (Manders’ overlap = ~0.4; Fig 2H2K), whereas ~23% of the PIKI-1::mNeonGreen signal overlapped with mKate2::RAB-5 (Manders’ overlap = ~0.23; Fig 2H2K). Additionally, the Pearson’s correlation coefficient (PCC = ~0.14) is consistent with partial overlap between mKate2::RAB-5 and PIKI-1::mNeonGreen (Fig 2L). These results indicate that PIKI-1 is associated with both clathrin-coated pits and endosomal trafficking compartments, raising the possibility that class II PI3K functions in endomembrane trafficking may be partially conserved between C. elegans and mammals. Additionally, Phyp7::PIKI-1::mNeonGreen likely localizes to additional endomembrane or other cytoplasmic compartments.

We next tested PIKI-1::mNeonGreen colocalization with four additional endomembrane compartment markers including GFP::RAB-7 (late endosomes), NUC-1::mCherry (lysosomes), Phyp7::mScarlet::RME-1 (RME-1–positive recycling endosomes), and CHAT-1::mKate (early endosomes and CHAT-1–positive recycling endosomes) [79,9799]. Notably, we did not observe strong co-localization with any of these markers, although PIKI-1 overlapped weakly with RAB-7 (S3 Fig) and CHAT-1 puncta often appeared adjacent to PIKI-1 puncta (S4 Fig). The slight overlap between PIKI-1 and RAB-7 could be explained by the partial localization of RAB-7 to “early” endosomes during the endosomal conversion process (early-to-late stages) [100103]. Moreover, flanking PIKI-1 and CHAT-1 signals may reflect the localization of these proteins to distinct sub-domains on early endosomes or to emergent recycling endosomes labeled by CHAT-1. Collectively, our findings indicate PIKI-1 localizes primarily to early endosomes and clathrin-coated pits but does not rule out targeting to additional endomembrane compartments.

Loss of PIKI-1 impacts a subset of endosomal compartments

Mammalian class II PI3Ks and the production of PI(3,4)P2 are implicated in the scission of nascent clathrin-coated vesicles and the subsequent uncoating and maturation of vesicles enroute to the early endosome [41,86,104]. To determine whether PIKI-1 regulates early steps of clathrin-mediated endocytosis in C. elegans, we examined markers for clathrin light and heavy chains in wild type and piki-1 mutants. Despite localization of PIKI-1 to clathrin-coated structures, piki-1(Q1507Stop) mutants showed a wild-type-like pattern of localization for both clathrin heavy (GFP::CHC-1) and light (mScarlet::CLIC-1) chains, suggesting that PIKI-1 does not play a major role in clathrin-mediated endocytosis in the worm epidermis (S5A–S5F Fig). Consistent with this, LRP-1, an apically expressed low-density lipoprotein–like receptor that is trafficked through apical clathrin-coated pits [105], showed only slightly increased accumulation at the apical surface in piki-1(Q1507Stop) worms as compared with wild type (S5G–S5I Fig). Together these data indicate that class II PI3K activity may be largely dispensable for clathrin-mediated endocytosis in the C. elegans epidermis.

After internalization at the plasma membrane, cargoes are sorted at early endosomes for subsequent routing to either recycling or degradative pathways (Fig 3A) [48,72]. To investigate the role of PIKI-1 at early endosomes, we examined two early endosomal markers, GFP::RAB-5 and GFP::EEA-1, in wild type and piki-1 mutants. RAB-5 is a small GTPase that recruits proteins required for endocytic sorting and transport, whereas EEA-1 is a conserved effector of RAB-5 that promotes vesicle docking and fusion (Fig 3A) [51,52]. Notably, we observed a marked (~1.5-fold) decrease in the number of RAB-5– and EEA-1–positive endosomes in piki-1(Q1507Stop) mutants as compared with wild type (Fig 3B3D and 3F3H). Moreover, the size of RAB-5– and EEA-1–positive puncta was reduced by ~1.5- and ~1.3-fold, respectively (Fig 3E and 3I). In contrast, reduction of PIKI-1 function had no detectable effect on the mean intensity or morphology of late endosomes marked by GFP::RAB-7 (S6A–S6D Fig), consistent with localization of PIKI-1 to early but not late endosomes (S3 Fig). These findings suggest that PIKI-1 plays a role in the biogenesis, homeostasis, or organization of early endosomes.

Fig 3. Reduction of PIKI-1 function affects different endosomal compartments.

Fig 3

(A) Schematic of endocytosis and associated endosomal compartments. Compartments are labeled in bold with associated proteins and cargos indicated. (B, C,F, G, H, J, K, N, O, R, and S) Representative confocal images of day-1 adults that were used to assess the markers (B, C) Prab-5::GFP::RAB-5, (F, G) Phyp7::GFP::EEA-1, (J, K) Phyp7::mNeonGreen::SNX-1, (N, O) Phyp7::TGN-38::GFP, and (R, S) Phyp7::AMAN-2::mNeonGreen in wild-type and piki-1(Q1507Stop) mutants. The seam cell is labeled in all images. Calculated metrics included (D, H, M and U) number of puncta per unit area; (E, I) Size (area) of puncta; (L, T) average mean intensity; (Q) percentage of positive pixels (above threshold). All dot plots show the mean and 95% CI. Statistical significance was determined using unpaired t-tests; ****p ≤ 0.0001; **p ≤ 0.01. (O) Red arrows indicate tubulations marked by TGN-38::GFP. (P) Statistical significance for tubulations was determined using Fisher’s exact test; ****p ≤ 0.0001. Raw data are available in S1 File.

To further investigate the role of PIKI-1 at early endosomes we examined the localization of the sorting nexin SNX-1 in the epidermis. SNX-1 is an ortholog of human SNX1 and SNX2, which bind PI(3)P and promote membrane bending and tubulation in part through interactions with the retromer complex, facilitating tubulation, cargo sorting, and the recycling of cargo from early endosomes to the trans-Golgi and plasma membrane [106110]. In C. elegans SNX-1 has been shown to localize to a sub-domain/population of early endosomes in intestinal cells and coelomocytes, consistent with localization data for SNX1 and SNX2 in mammalian cells [107,111114]. Likewise, we observed partial co-localization of a Phyp7::mScarlet::SNX-1 epidermal reporter with both GFP::RAB-5 and PIKI-1::mNeonGreen (Fig 4). In contrast to RAB-5 and EEA-1, however, loss of piki-1 led to a ~ 1.4-fold increase in the average mean intensity of a Phyp7::mNeonGreen::SNX-1 epidermal reporter and to a ~ 1.2-fold increase in the density of SNX-1–marked puncta (Fig 3J3M). Taken together, our data suggest that PIKI-1 promotes RAB-5 and EEA-1 association while restricting SNX-1 binding, thereby influencing the composition of membrane domains at early endosomes.

Fig 4. SNX-1 colocalizes with the early endosome markers RAB-5 and PIKI-1.

Fig 4

(A–C’ and F–H’) Colocalization of young adult worms expressing heterozygous Phyp7::mScarlet::SNX-1 with (A–C’) heterozygous GFP::RAB-5 (n = 22) or (F–H’) heterozygous Phyp7::PIKI-1::mNeonGreen (n = 18). Yellow squares correspond to enlarged insets; yellow arrows indicate examples of colocalization (white). The seam cell is labeled in A–C and F–H. Colocalization was quantified using Mander’s overlap (D, I) and Pearson’s correlation coefficients (E, J). Dot plots show the mean and 95% CI. Statistical significance between rotated and inset values was determined using unpaired t-tests; ****p ≤ 0.0001; ***p ≤ 0.001. Raw data are available in S1 File.

Several studies have implicated mammalian Class II PI3Ks in regulating cargo recycling pathways [55,87,115]. To assess the role of PIKI-1 in C. elegans endocytic recycling, we examined the localization of GFP::RAB-11 and mNeonGreen::RME-1 in piki-1 mutants. In the worm epidermis, RAB-11 marks a basal–medial recycling compartment, which may be equivalent to the endocytic recycling compartment (ERC) in mammals, whereas RME-1 marks a distinct population of apical recycling endosomes [74,79]. Notably, reduction of PIKI-1 had no obvious effects on RME-1-marked endosomes and only minimal effects on the GFP::RAB-11 marker including a ~ 1.1-fold decrease in mean intensity (p = 0.0012) and a modest (though not statistically significant) decrease (~1.3-fold; p = 0.15) in the size of the GFP::RAB-11 puncta (S6E–S6L Fig). As such, PIKI-1 appears to have at most a minor or indirect role on the assayed recycling compartments.

We also examined localization of the cargo protein TGN-38, which travels from the trans Golgi to the plasma membrane during exocytosis and is recycled back to the Golgi via early endosomes, potentially bypassing the RAB-11 compartment [116,117]. Although no changes in mean intensity of TGN-38::GFP were observed between wild type and piki-1(Q1057Stop) mutants (S5J Fig), we noticed a striking tubulation phenotype, as marked by TGN-38::GFP, in ~50% of piki-1(Q1507Stop) worms (Fig 3N3P). Additionally, we detected a ~ 30% decrease in the percentage of TGN-38::GFP–positive pixels (above threshold) in piki-1(Q1057Stop) animals (Fig 3Q), suggesting a redistribution and accumulation of TGN-38 to more tubular structures. These data suggest that PIKI-1 plays a role in the transit of TGN-38 through the endocytic sorting and recycling pathways, although the compartmental identity of the TGN-38–positive tubules is currently unknown.

Given our findings for TGN-38, we assessed the impact of PIKI-1 loss on the Golgi using a AMAN-2::mNeonGreen marker [118]. AMAN-2 is a homolog of mammalian alpha-mannosidase II (Man II), a resident Golgi protein that has been shown to be distributed throughout the Golgi in a cell type–dependent fashion [119,120]. Notably, we observed an ~ 1.4-fold reduction in the mean intensity of AMAN-2::mNeonGreen in piki-1(Q1507Stop) mutants along with a modest decrease in the number of AMAN-2 puncta (~1.2-fold) (Fig 3R3U) but with relatively little change in morphology. We note that although our available markers did not allow us to directly test for PIKI-1 localization to Golgi, the distinct locations of AMAN-2::mNeonGreen and PIKI-1::mNeonGreen puncta along the apicobasal axis of hyp7 was not suggestive of a substantial overlap. Our results suggest that defects in the sorting and/or transport of cargo from the early endosome to the Golgi in piki-1 mutants may indirectly impact the size of the Golgi compartment.

PIKI-1 has been reported to promote the clearance of phagosomes in the developing embryo and adult germline through the production of PI(3)P [88,9092]. We therefore asked whether PIKI-1 was required for the normal localization of the downstream phagosome/autophagy effector, LGG-1, in the adult hyp7 (Fig 3A) [121124]. We observed a modest reduction (~1.3-fold) in the mean intensity of mNeonGreen::LGG-1 in piki-1(Q1507Stop) mutants relative to wild type as well as an increase in the frequency of elongated or tubular structures marked by LGG-1 (38%) versus wild type (10%) (S6M–S6P Fig). Although suggestive of a function for PIKI-1 in autophagy, the nature of the compartment marked by mNeonGreen::LGG-1 is currently unclear. Collectively, our data suggest several roles for PIKI-1 in membrane trafficking in hyp7 including the maintenance of early endosome subdomains, cargo recycling from the early endosome to the Golgi, and a potential role in canonical or non-canonical autophagy.

Loss of PIKI-1 suppresses defects in early endosomes associated with NEKL-2 depletion

Based on the above findings, we were curious as to how loss of piki-1 might lead to the genetic suppression of nekl-2; nekl-3 mutants. We had previously observed localization of NEKL-2 to early endosomes (GFP::RAB-5) and shown that depletion of NEKL-2, using the auxin-inducible degron (AID) system, results in an expansion of the RAB-5–marked early endosome compartment [74]. To determine if loss of piki-1 alleviates defects at early endosomes following NEKL-2::AID depletion, we compared GFP::RAB-5 localization in auxin-treated nekl-2::AID and nekl-2::AID; piki-1(Q1507Stop) adults. Consistent with prior findings, we observed ~1.4-fold increases in both total mean intensity and puncta size as well as a ~ 1.2-fold increase in the number of GFP::RAB-5 puncta following NEKL-2::AID depletion (Fig 5A, 5B, and 5D5F). Notably, this expansion of the GFP::RAB-5 compartment was prevented when NEKL-2::AID was depleted in the piki-1(Q1507Stop) background. Specifically, we observed a decrease in the mean intensity (~1.3-fold), size (~1.8-fold), and number of RAB-5–marked puncta (~1.2-fold) in nekl-2::AID; piki-1(Q1507Stop) adults relative to nekl-2::AID alone (Fig 5B5F). Overall, the early endosome compartment in NEKL-2–depleted piki-1(Q1507Stop) worms was comparable to wild-type, albeit with a modest reduction in puncta size (~1.3-fold). The reversal of nekl-2-associated early endosome defects by piki-1 suggests a possible means by which piki-1 mutations may suppress nekl-2; nekl-3 molting defects.

Fig 5. Loss of PIKI-1 suppresses nekl-2–associated defects in the early endosome.

Fig 5

(A–C) Representative confocal images of Prab-5::GFP::RAB-5 expression in auxin-treated day-2 adults in (A) wild-type, (B) nekl-2::AID, and (C) nekl-2::AID; piki-1(Q1507Stop) backgrounds. (D–F) Dot plots show (D) mean intensity, (E) puncta size, and (F) the number of puncta per unit area for Prab-5::GFP::RAB-5. (G–I) Representative confocal images of GFP::CHC-1 expression in auxin-treated day 2 adults in (G) wild-type, (H) nekl-3::AID, and (I) nekl-3::AID; piki-1(Q1507Stop) backgrounds. (J, K) Dot plots show the (I) mean intensity and (J) percent positive pixels (above threshold). (A–C and G–I) The seam cell is labeled in all images. (D–F and J, K) Dot plots show the mean and 95% CI. Statistical significance was determined using unpaired t-tests; ****p ≤ 0.0001, **p ≤ 0.01, *p ≤ 0.05; ns, not significant. Raw data are available in S1 File.

In contrast, loss of piki-1 did not alleviate clathrin localization defects following depletion of AID-tagged NEKL-3. Consistent with our prior work [75] we observed an increase in apical GFP::CHC-1 following NEKL-3::AID depletion, leading to an a ~ 1.3-fold increase in mean intensity and a 2.4-fold increase in the percentage of CHC-1::GFP–positive pixels (above threshold) (Fig 5G, 5H, 5J, and 5K). Similarly, NEKL-3::AID–depleted piki-1(Q1507Stop) worms showed a ~ 1.4-fold increase in mean intensity and a ~ 2.2-fold increase in the percentage of positive pixels (Fig 5G, 5I, 5J, and 5K). Taken together, our results indicate that loss of PIKI-1 may alleviate a subset nekl-associated trafficking defects, most notably those associated with early endosomes.

Loss of PIKI-1 alters polyphosphoinositide pools in the epidermis

To understand more precisely how PIKI-1 regulates membrane phospholipids, we generated lipid sensors to investigate the distribution of PPIns species in wild type and piki-1 mutants. Class II PI3Ks contribute to the generation of two distinct lipid species, PI(3)P and PI(3,4)P2, which in turn recruit specific proteins to cytosolic-facing membranes [21]. We expressed fluorescently tagged lipid biosensors under the control of epidermal-specific promoters (Phyp7 or Pnekl-3) [79,125,126], where each biosensor was integrated as a single copy using miniMos methods or was maintained as an extrachromosomal array (see S2 File and Materials and Methods) [94].

In mammalian cells, PI(3)P is associated with early endosomes as well as with autophagosomes and nuclei [127]. Consistent with this, our PI(3)P sensor (Phyp7::2xFYVE::mNeonGreen) localized to punctate structures close to the apical surface in wild-type adults as well as to more basally located hyp7 nuclei (Fig 6A). piki-1(Q1507Stop) mutants exhibited a similar pattern of PI(3)P localization, although we detected a slight decrease (~1.2-fold) in the number of vesicles relative to wild type (Fig 6B and 6C). Likewise, the piki-1(ok2346) deletion mutant displayed a similar modest decrease in the number of PI(3)P-marked vesicles (S7B–S7D Fig). The absence of a strong effect on PI(3)P is consistent with previous work demonstrating that class III PI3Ks can be the predominant producers of PI(3)P [10,92]. To further examine PI(3)P localization, we carried out colocalization analysis of the PI(3)P sensor with an early endosome marker, mKate2::RAB-5 [128]. Approximately 32% of the mKate2::RAB-5 signal overlapped with our PI(3)P sensor (Manders’ overlap = 0.32) and ~65% of PI(3)P-labeled puncta overlapped with the mKate2:RAB-5 signal (Manders’ overlap = 0.65; Fig 7A7D). This substantial overlap is further supported by the Pearson’s correlation coefficient (PCC = 0.37; Fig 7E). Thus, PI(3)P pools, which were slightly reduced by loss of PIKI-1, are associated with early endosomes, consistent with our findings for PIKI-1 localization. Our findings also suggest that PI(3) localizes to membrane domains or compartments other than RAB-5–marked endosomes and that portions of RAB-5–positive endosomes may not contain substantial levels of PI(3).

Fig 6. Loss of PIKI-1 affects PI(3)P and PI(3,4)P2 pools in the epidermis.

Fig 6

(A,B,D,E,H,I,K and L) Representative confocal images of day-1 adult worms expressing lipid sensors for (A, B) PI(3)P [Phyp7::2xFYVE::mNeonGreen], (D, E) PI(3,4)P2 [Pnekl-3::2xTAPP1::mNeonGreen], (H, I) PI(4,5)P2 [Phyp7::PH PLC δ::mNeonGreen], and (K, L) PI(3,4,5)P3 [Pnekl-3::BTK PH::mNeonGreen] in (A, D, D’ H and K) wild-type and (B,E, E’, I and L) piki-1(Q1507Stop) backgrounds. The seam cell is labeled in all images; example nuclei (nuc) are also indicated in panels A and B. (D’, E’) Representative confocal images of day-1 adult worms expressing Pnekl-3::2xTAPP1::mNeonGreen that have been processed using the 2D deconvolution algorithm in CellSens 4.2. (C) Puncta per unit area for worms expressing Phyp7::2xFYVE::mNeonGreen. (F, J and M) The mean intensity for worms expressing (F) Pnekl-3::2xTAPP1::mNeonGreen, (J) Phyp7::PH PLC δ::mNeonGreen, and (M) Pnekl-3::BTK PH::mNeonGreen. Dot plots show the mean and 95% CI. (G) The percentage of viable adults after injection of dsRNA for F55D12.2 and hipr-1 relative to control uninjected nekl-2; nekl-3 worms. Statistical significance was determined using unpaired t-tests (C, F, J and M) or Fischer’s exact test (G). ****p ≤ 0.0001, ***p ≤ 0.001; ns, not significant. Raw data are available in S1 File.

Fig 7. PI(3)P and PI(3,4)P2 localize at the early endosome.

Fig 7

(A–C’ and F − H’) Colocalization assays were carried out in worms expressing Pdpy-7::mKate2::RAB-5 and (A–C’) the PI(3)P lipid sensor [Phyp7::2xFYVE::mNeonGreen] (n = 15) or (F–H’) the PI(3,4)P2 lipid sensor [Pnekl-3::2xTAPP1::mNeonGreen] (n = 30). The seam cell is labeled (A–H); yellow squares (A–C and F–H) indicate the enlarged insets (A’–C’ and F’–H’). In merged insets (C’ and H’), yellow arrows indicate examples of colocalization. (D, E, I and J) Colocalization was quantified using Mander’s overlap (D, I) and Pearson’s correlation coefficient (E and J). Dot plots show the mean and 95% CI. Statistical significance between rotated and inset values was determined using unpaired t-tests; ****p ≤ 0.0001. Raw data available in S1 File.

Like PI(3)P, PI(3,4)P2 has been associated with early endosomes as well as with endocytic recycling compartments [23,56]. Additionally, PI(3,4)P2 is found on the apical membrane of polarized epithelial cells [58]. In wild type, the PI(3,4)P2 sensor (Pnekl-3::2xTAPP1::mNeonGreen; fdSi8) exhibited a diffuse localization pattern in both apical and basal planes but also accumulated at apical puncta (Fig 6D and 6D’ and S1 Movie). We note that the diffuse expression of the PI(3,4)P2 sensor may be due in part to the sensor being present in excess of its preferred ligand, a known caveat associated with genetically encoded lipid sensors [26]. Strikingly, reduction of PIKI-1 function led to a 1.9-fold decrease in the amount of the PI(3,4)P2 present in the epidermis (Fig 6D6F), consistent with PIKI-1 acting as a major producer of PI(3,4)P2. The decreased abundance of the lipid-sensor may be attributable to a reduction in lipid-binding sites and increased reporter turnover, as has been reported [6971,129,130]. Correspondingly, there was no observed accumulation of the lipid sensor at a more basal plane in piki-1(Q1507Stop) mutants (S2 Movie).

Notably, our PI(3,4)P2 sensor (fdEx406) showed substantial colocalization with the mKate2::RAB-5 marker; ~ 62% of the mKate2::RAB-5 signal overlapped with the PI(3,4)P2 sensor and ~25% of the PI(3,4)P2 sensor overlapped with mKate2::RAB-5 (Fig 7F7I). Significant positive but partial overlap was also supported by the Pearson’s correlation coefficient (PCC = 0.16; Fig 7J). These results suggest that a sizeable proportion of early endosomes are marked by PI(3,4)P2, the production of which is dependent in large part on PIKI-1. As with the PI(3)P sensor, our results indicate that PI(3,4)P2 may localize to specific populations or subdomains of early endosomes but also suggest that PI(3,4)P2 is also present on additional compartment membranes, such as small protrusions and tubules emanating from early endosomes or apical recycling endosomes (Figs 7F7J and S7A).

The PPIns biosynthesis pathway is highly interconnected, with multiple lipid kinases and phosphatases contributing to the production of individual PPIns species (Fig 1B). As such, changes in the levels of one PPIns species have the potential to affect other pools [131]. To investigate whether loss of PIKI-1 affects other PPIns populations, we generated lipid sensors to visualize PI(4,5)P2 (PH PLC δ::mNeonGreen), a PPIns involved in clathrin-mediated endocytosis in mammalian cells, and PI(3,4,5)P3 (Pnekl-3::BTK PH::mNeonGreen), a PPIns associated predominantly with the plasma membrane and phagosome formation that can be converted to PI(3,4)P2 [2,3,5,6,12,16,43,49,132]. In wild type, the PI(4,5)P2 sensor localized throughout hyp7 to folded plasma membrane subdomain compartments that likely represent meisosomes [133], where PI(4,5)P2 is known to be expressed (Fig 7H). Notably, this marker was unchanged in piki-1(Q1507Stop) and piki-1(ok2346) worms (Figs 6H6J and S7ES7G). Likewise, no obvious changes were observed for the PI(3,4,5)P3 sensor in piki-1(Q1507Stop) mutants, which exhibited a diffuse localization pattern but also accumulated at variably sized puncta throughout the epidermis (Fig 6K6M). Our combined results indicate that reduction of PIKI-1 most strongly affects PI(3,4)P2 pools with a limited impact on other species of PPIns, most notably PI(3)P. We note that, although not assayed, PI(4)P pools in the epidermis may also be expected to increase in piki-1 mutants and may contribute to the observed trafficking phenotypes [134138].

Lastly we tested a putative multi-specific lipid sensor reported to recognize both PI(3,4)P2 and PI(3,4,5)P3 (AKT::oxGFP), but which may bind to other lipids and endogenous proteins [69,139]. In wild-type animals, the localization of the dual-specificity sensor most closely resembled that of the PI(3,4)P2 sensor, with combined diffuse localization accompanied by distributed puncta (S8A Fig). Curiously, the AKT::oxGFP reporter exhibited a dramatic tubulation phenotype in ~50% of piki-1(Q1507Stop) and piki-1(ok2346) mutants (S8B–S8G Fig), reminiscent of the phenotype of piki-1 mutants expressing TGN-38::GFP. Given that lysosomes can form elongated tubules in the epidermis during normal molting cycles [98], we assessed two lysosomal markers, LMP-1::mNeonGreen [127] and NUC-1::mCherry [140], in piki-1 mutants. LMP-1 is a conserved lysosomal membrane protein involved in lysosome biogenesis [141] whereas NUC-1 is a lysosomal hydrolase that acts within the lysosomal compartment [140]. Notably, we did not observe tubulation of either marker in piki-1(Q1507Stop) mutants (S9 Fig), indicating that the tubulations detected with the dual-specificity marker are unlikely to be lysosomal in origin. We note, however, that NUC-1::mCherry–positive vesicles were more abundant but slightly smaller in piki-1(Q1507Stop) mutants, suggesting that PIKI-1 may directly or indirectly affect lysosomal compartments (S9D–S9G Fig). Our findings suggest that the tubulations observed with the AKT::oxGFP marker, as well as with TGN-38::GFP, may be extensions of sorting or recycling endosomal compartments, although they were not marked by any of our tested proteins.

nekl defects may be suppressed by inhibition of PI(3,4)P2 binding proteins

Our findings suggest that a reduction of PI(3,4)P2 is responsible for the genetic suppression of nekl-2; nekl-3 mutants by piki-1 mutants. Moreover, a reduction of PI(3,4)P2 would be expected to affect the binding of specific endocytic regulators to compartments including the early endosome. We therefore hypothesized that inhibition of one or more PI(3,4)P2-binding proteins may contribute to the suppression of nekl-2; nekl-3 mutants. To test this, we looked for potential PI(3,4)P2-binding proteins involved in endocytic trafficking based on gene ontology terms. From this search, we identified two potential PI(3,4)P2 interactors: F55D12.2, an ortholog of human SESTD1 (SEC14 and spectrin domain containing 1), which regulates lipid signaling [142], and HIPR-1, an ortholog of human HIP1 and HIPR1 (Huntingtin-Interacting Protein 1 [Related Protein]), proposed to regulate clathrin-mediated endocytosis and vesicular trafficking by linking endocytic proteins to the actin cytoskeleton [143]. Whereas inhibition of F55D12.2 by RNAi failed to suppress molting defects in nekl-2; nekl-3 worms, possibly due to insufficient knockdown, hipr-1(RNAi) resulted in ~39% of nekl-2; nekl-3 worms reaching adulthood (Fig 6G). Together, our findings are consistent with a model wherein reduced levels of PI(3,4)P2, along with an accompanying reduction in the binding of PI(3,4)P2-associated proteins such as HIPR-1, may contribute to the partial restoration of trafficking functions in nekl mutants and ultimately to the suppression of nekl-2; nekl-3 molting defects.

Discussion

Using a forward genetic approach to identify suppressors of nekl-associated molting defects, we isolated three independent alleles of the lipid modifier PIKI-1 and established a novel link between class II PI3K enzymes and NEKL protein kinases, which are essential for molting and epidermal membrane trafficking in C. elegans. We find that PIKI-1 regulates several endocytic processes in the epidermis, including a prominent role at early endosomes. PIKI-1 partially localizes to early endosomes, and its inhibition leads to a reduction in the size and number of membrane-bound structures marked with RAB-5 or EEA-1. Conversely, loss of PIKI-1 led to an expansion of the SNX-1–marked early endosome compartment, suggesting that PIKI-1 may be important for maintaining a balance between endosomal sub-compartments or microdomains. These phenotypes may be due to the combined effects of strongly reduced PI(3,4)P2, modestly reduced PI(3)P, or increased PI(4)P, along with secondary effects on the lipid and protein composition of early endosomes in piki-1 mutants. Notably, SNX1 and SNX-2 have a greater in vivo affinity for PI(3)P and PI(3,5)P2 than for PI(3,4)P2, potentially providing an explanation for the expansion of SNX-1 in piki-1 mutants [106,107].

In addition to early endosomes, our expression studies indicated that PIKI-1 localizes to clathrin-coated pits, consistent with findings in mammalian cells [10,12,14,38,48,70]. Cell culture studies have shown that class II PI3Ks act at clathrin coated pits to produce PI(3,4)P2, which then recruits proteins necessary for the completion of vesicle budding and the internalization of cargo [57,86]. However, PIKI-1 appeared to be largely dispensable for clathrin-mediated endocytosis in the C. elegans epidermis. This discrepancy may reflect differences in the mechanisms controlling endocytosis in polarized versus non-polarized cells or may be due to additional differences between cell types and species [144,145].

Using genetically encoded lipid-biosensors, we found that PIKI-1 is a major producer of PI(3,4)P2 and a minor contributor to PI(3)P pools in hyp7. Both PI(3)P and PI(3,4)P2 are found in association with early endosomes in the hyp7, consistent with a direct role for PIKI-1 in the production of these PPIns species. Other genetic data are consistent with PIKI-1 being the major producer of PI(3,4)P2 in the epidermis. For example, we failed to observe genetic interactions when other pathway components that may contribute PI(3,4)P2 synthesis were inhibited (age-1 and inpp-1). However, these findings may reflect a failure to sufficiently reduce the expression of these genes, and we cannot rule out a role for alternative pathways in the production of PI(3,4)P2 via the 5’ dephosphorylation of PI(3,4,5)P3 produced by Class I PI3Ks. In contrast, loss of PIKI-1 did not appear to affect PI(3,4,5)P3 or PI(4,5)P2 levels.

Reduction of PIKI-1 also resulted in hyper-tubulation defects based on a multi-specific lipid sensor (AKT-PH::GFP), as well as TGN-38, a trans-Golgi cargo that cycles through early endosomes, and LGG-1, a marker for phagosomes and autophagosomes. Although lysosomes in C. elegans form elongated tubules during molting cycles [98], our studies did not support a major role for PIKI-1 in controlling the morphology of lysosomes. Moreover, lack of tubulations emanating from the Golgi (AMAN-2::GFP) in piki-1 mutants suggests that the observed TGN-38 tubulations may arise from an early endosomal compartment. We speculate that loss of PIKI-1 may lead to defects in cargo sorting and/or endosomal tubule scission, leading to the observed tubules in piki-1 mutants. Consistent with this idea, the PI(3,4)P2 biosensor, 2xTAPP1, labeled shorter protrusions and tubule-like extensions associated with RAB-5 positive puncta.

Previous studies in C. elegans embryos and in the adult gonad indicate that PIKI-1 is required for the maturation and clearance of phagosomes following cell corpse engulfment [8892]. Initially VPS-34 (a Class III PI3K), but not PIKI-1, was suggested to be the major producer of PI(3)P on embryonic phagosomes and autophagosomes [89]. However, other work indicated that PIKI-1, acts coordinately with VPS-34 and MTM-1 (a 3-phosphatase), to produce PI(3)P on embryonic phagosomes as well as in the germline (Fig 1B) [88,90,92]. Collectively these data suggest that the role of PIKI-1 in PI(3) production may be cell-type specific or confined to specific developmental time points.

In prior studies of the nekls, we identified several genetic suppressors with established roles in membrane trafficking including proteins controlling clathrin-mediated endocytosis, membrane lipid asymmetry, and endosomal-associated actin [7476,78,79]. Other nekl suppressors appear to act independently of membrane trafficking per se and include regulators of cargo processing, cell signaling, and development [80,146148]. Our current findings suggest that loss of PIKI-1 leads to the suppression of nekl molting defects through a mechanism that partially alleviates nekl trafficking defects at early endosomes. We propose that loss of PIKI-1 interferes with the functions of PI(3,4)P2-binding proteins, such as HIPR-1, inhibition of which led to the suppression of nekl-2; nekl-3 molting defects.

Broadly speaking, our results suggest that PIKI-1 and NEKL-2 may act in opposition given that loss of piki-1 and depletion of NEKL-2::AID lead to apparent opposite effects on early endosomes [74]. Although our studies do not reveal a precise molecular connection, it is possible that PIKI-1 is a direct or indirect target for negative regulation by NEKL-2. Consistent with this, we recently identified PIKI-1 as a proximal interactor of NEKL-2 in the epidermis, raising the possibility that NEKL-2 may associate with and directly influence PIKI-1 activity [149]. More generally, our current and prior studies suggest that inhibition of the nekls leads to defective trafficking at multiple points within the endomembrane system, which lead to molting defects in part through the reduced uptake of sterol precursors required for molting gene transcription [7375,78,79,147]. We further speculate that molting defects in nekl mutants can be partially alleviated by correcting for a subset of nekl-associated trafficking defects, consistent with our previous studies [74,75,78,79]. Future studies combining genetic, proteomic, and biochemical assays are expected to provide deeper insights into how conserved NIMA-related kinases regulate endocytic trafficking in conjunction with conserved trafficking components.

Materials and methods

Strains and propagation

All C. elegans strains were maintained per standard protocols and propagated at 22°C unless stated otherwise [150]. Strains in this study are listed in Table A in S2 File.

RNAi

Standard dsRNA injection methods were used to conduct RNAi experiments [151]. Primers containing the T7 RNA polymerase–binding motif and corresponding to piki-1, age-1, inpp-1, inpp-4b, F55D12.2, and hipr-1 were used to synthesize dsRNA using the MEGAscript RNAi Kit (Invitrogen). dsRNA was injected at concentrations of 500–1000 ng/μL. Primer information is in Table B in S2 File.

CRISPR mutant alleles

Alleles of piki-1 (Q1507Stop) were created using established CRISPR-Cas9 protocols [152154]. sgRNA and repair templates were synthesized by Integrated DNA technologies and Dharmacon-Horizon Discovery; ApE and CRISPRcruncher were used in the design of the guideRNA and repair templates [154,155]. Primer, sgRNA, and repair template sequences are provided in Table C in S2 File.

Reporter strain construction

Plasmids for C. elegans epidermal-specific expression in the hyp7 syncytium used promoters for semo-1/Y37A1B.5 (Phyp7) and nekl-3 (Pnekl-3) as previously described [74,75,79]. We generated pDONR221 entry vectors containing coding regions for C. elegans piki-1 (gift from Zheng Zhou, Baylor College of Medicine) [92], human 2x-TAPP1, wherein the second repeat was codon optimized for C. elegans [156] and contained synthetic introns to promote expression (Integrated DNA Technologies); human AKT [139] and human BTK (Addgene Plasmid #51463) [157]. Cloning of the PH-domain from human AKT (pDONR221 AKT) into destination vector pCFJ1662 Psemo-1::GTWY::oxGFP::let-858 (35G7) [74,125,126] was performed using the Gateway LR clonase II reaction (Invitrogen). piki-1 and BTK pDONR221 clones were transferred into destination vector pCFJ1662 Phyp7::GTWY::mNeonGreen::let-858 (34H4) via the Gateway LR clonase II reaction. The 2X-TAPP1 pDONR221 clone was transferred into destination vector Pnekl-3::GTWY::mNeonGreen::let-858 (pDF477, derived from pCFJ1662 (34H4)) [79] using the Gateway LR clonase II reaction. To generate single-copy integrations, standard miniMos procedures were followed [94]. In cases where we were unable to obtain integrations, we co-injected the expression clone and a plasmid containing unc-119(+) into a background of unc-119(ed3) and used the resulting stable extrachromosomal array in our analyses (fdEx405, fdEx406, S2 File).

Auxin treatment

Indole-3-acetic acid (auxin) from Alfa Aesear was used to make a 100 × stock auxin solution (0.4 M) by dissolving 0.7 g of auxin in 10 mL of 100% ethanol. For experiments, a mixture of 25 µL of stock auxin solution and 225 µL of autoclaved deionized water was added to NGM plates spotted with OP50 with day-1 adult worms present, at least 18 hours before imaging [75,94,158].

Image acquisition

Fluorescence images were acquired using an Olympus IX83 P2ZF inverted microscope with a Yokogawa spinning-disc confocal head (CSU-W1). z-Stack images were acquired using a 100 × 1.35 N.A. silicone oil objective. cellSens 4.2 software (Olympus Corporation) was used for image acquisition with a Hamamatsu-ORCA-Fusion camera. For each worm, z-stack slices were acquired every 0.2 µm for ~20 slices to encompass the epidermis of the worm.

Image analysis to determine fluorescence, size, puncta per unit area, and percent positive pixels

All image analysis and quantification, was done using Fiji [159]. To quantify the mean intensity (measured in arbitrary units, a.u.), the intensity of the background of the image was first measured using the rectangle selection tool in an area of the image where there was no visible fluorescence. The resulting value was subtracted from the mean intensity value obtained from the epidermis (hyp7) of each animal in each picture, by using the polygon selection tool to select the appropriate region of interest (ROI) [74,79].

To quantify the average area of vesicles, number of puncta, or the percent positive pixels above threshold for a z-plane of interest which corresponds to a single slice at an appropriate plane from the obtained z-stacks, images underwent processing to remove background. This was done through application of the rolling ball background subtraction method (in which background intensity values below the average within a 50-pixel radius surrounding a positive pixel are subtracted (Figs 3F, 3G, 3J and 3K 3N, 3O, 3R, 3S, and S9). For images for which rolling ball background subtraction did not work well, we used the minimum filter method (in which the central pixel is compared to other pixels within a 10-pixel radius and the minimum value in the window is replaced with the central pixel value to reduce noise (Figs 3B, 3C, S5A, S5B, S5D, S5E, S5G, S5H, S6A, S6B, S6E, S6F, S6I, S6J, S6M, and S6N). The filtered image was subtracted from the raw image using the image calculator function. After processing, all images were thresholded using the algorithm that worked best (or a manual threshold set using representative images; see S1 File for details and raw data). The “Despeckle” function was subsequently applied to all images to remove signal noise of ≤1pixel in size. Then the “Analyze Particles” function was applied to the processed images to determine the average area of vesicles. Within each experiment, the same background subtraction and threshold algorithms were used for all images. To account for variation in the size of the region of interest (ROI; drawn using the polygon tool to select hyp7 and exclude the seam cell) measured among worms, the number of puncta was divided by the area of the ROI (output in units of puncta per square micron).

Image analysis to determine colocalization

All image analysis for colocalization was carried out on day-1 adults. For quantifying colocalization, the raw z-stack images were deconvoluted using the 2D deconvolution algorithm available in cellSens (ver. 4.2). The appropriate z-plane was then extracted from both the raw and deconvoluted images for each channel. To obtain a binary image to be used as a mask, deconvoluted images were thresholded. This binary mask was then combined with the raw image using the “AND” Boolean operation. The ROI was drawn around hyp7, excluding the seam cell, by using the polygon tool. To calculate the Pearson’s correlation coefficient (R) and Mander’s overlap (M) for these experiments, we used the BIOP JACoP plugin [160]. Merged images (containing both red and green channels) were used to determine the cases of significant overlap versus random co-occurrence. From these merged images, a small inset of 100 × 100 pixels (10,000 pixels2) was sampled, and the R and M values were calculated using the BIOP JACoP plugin (shown as “inset” in the resulting graphs). To create a random distribution of green and red pixels of interest as a control against random coincidence, the red channel was rotated 90° in relation to the green channel using the transform function before the R and M values were calculated using the BIOP JACoP plugin (shown as “rotated”) [79,161].

For convenience, some colocalization studies were carried out using strains that were trans-heterozygous for the tested markers (Figs 2HL, 4, and S4). In the case of the PIKI-1::mNeonGreen and mKate2::RAB-5 markers, we noticed that homozygous worms exhibited ectopic expression of PIKI-1::mNeonGreen in the seam cell with strongly reduced expression in hyp7 (S10 Fig), suggesting a genetic interaction induced by the fluorescent tags or an overexpression artifact. Importantly, trans-heterozygous PIKI-1::mNeonGreen and mKate2::RAB-5 marked worms exhibited expression of PIKI-1::mNeonGreen specifically in hyp7, similar to the parental homozygous strains.

Image analysis for phenotypes

Worms expressing Phyp7::AKT::GFP were scored based on the appearance of the marker throughout the entire epidermis. Worms were considered to have diffuse expression if there was a uniform architecture of the GFP signal and the boundary between hyp7 and the seam cell was clear. Worms were considered to have aggregates if there were at least three large aggregations present within the z-stack that were not uniform in size or morphology and were distinct from the background and nuclear expression. Worms with tubulations had elongated compartments originating from two or more sites in hyp7. All worms expressing AKT::GFP that exhibited tubulations also contained aggregations.

Worms expressing TGN-38::GFP or mNeonGreen::LGG-1 were scored based on the absence or presence of tubulations within the epidermis. Tubulations were defined as being longer, extended vesicles or longer, thin protrusions extending through the epidermis.

Statistical analysis

GraphPad Prism software was used to perform statistical tests in accordance with standard methods [162].

Supporting information

S1 Fig. RNAi of additional PPI modifiers.

(A) The proportion of viable progeny produced by nekl-2(fd81); nekl-3(gk894345) worms after injection by the indicated dsRNAs. (B) The proportion of viable progeny produced by nekl-2(fd81); nekl-3(gk894345) worms for the indicated genotype. Statistical significance was determined using Fischer’s exact test; ****p ≤ 0.0001, ***p ≤ 0.001. Error bars indicate and 95% CI. Raw data available in this File.

(TIFF)

pgen.1011740.s001.tiff (3.3MB, tiff)
S2 Fig. Endogenous CRISRP-Cas9 PIKI-1 expression.

(A, B) Representative confocal images of day-1 adults expressing CRISPR-tagged (A) PIKI-1::GFP and (B) PIKI-1::mScarlet. Note that accumulations present in the PIKI-1::mScarlet strain are likely the result of cleavage of mScarlet and its retention in lysosomes.

(TIFF)

pgen.1011740.s002.tiff (2.9MB, tiff)
S3 Fig. PIKI-1 does not colocalize with late endosomes or lysosomes.

(A–C’ and F–H’) Colocalization of young adult worms expressing Phyp7::PIKI-1::mNeonGreen with (A–C’) GFP::RAB-7 and (F–H’) NUC-1::mCherry. Yellow squares correspond to enlarged insets; yellow arrows indicate examples of colocalization (white). The seam cell is labeled in lower-magnification images. Colocalization was quantified using Mander’s overlap (D, I) and Pearson’s correlation coefficients (E, J). Dot plots show the mean and 95% CI. Statistical significance between rotated and inset values was determined using unpaired t-tests; ns, not significant. Raw data are available in S1 File.

(TIFF)

pgen.1011740.s003.tiff (15.9MB, tiff)
S4 Fig. PIKI-1 does not colocalize with two recycling compartment markers.

(A–C’ and F–H’) Colocalization of young adult worms expressing heterozygous Phyp7::PIKI-1::mNeonGreen with (A–C’) heterozygous Phyp7::mScarlet::RME-1 (n = 24) or (F–H’) heterozygous CHAT-1::mKate (n = 20). Yellow squares correspond to the enlarged insets; yellow arrows indicate examples of colocalization (white). The seam cell is labeled in A–C and F–H. Colocalization was quantified using Mander’s overlap (D, I) and Pearson’s correlation coefficient (E, J). Dot plots show the mean and 95% CI. Statistical significance between rotated and inset values were determined using unpaired t-tests; ns, not significant. Raw data are available in S1 File.

(TIFF)

pgen.1011740.s004.tiff (16.6MB, tiff)
S5 Fig. Effects of reduction of PIKI-1 function on clathrin and cargos.

(A, B, D, E, G and H) Representative confocal images of day-1 adults in wild-type and piki-1(Q1507Stop) mutants expressing (A, B) GFP::CHC-1, (D, E) mScarlet::CLIC-1, and (G, H) Phyp7::LRP-1::GFP. The seam cell is labeled in all images. (C, F, and I) Mean intensities corresponding to markers shown in the left-hand panels; (J) Mean intensity for TGN-38::GFP in wild-type and piki-1(Q1507Stop) mutants (also see Fig 3M and 3N). Dot plots show the mean and 95% CI. Statistical significance was determined using unpaired t-tests; *p ≤ 0.05; ns, not significant. Raw data are available in S1 File.

(TIFF)

pgen.1011740.s005.tiff (11.2MB, tiff)
S6 Fig. Effects of reduction of PIKI-1 function on additional endocytic compartments.

(A, B, E, F, I, J, M and N) Representative confocal images of day-1 adults in wild-type and piki-1(Q1507Stop) mutants expressing (A, B) GFP::RAB-7, (E, F) Phyp7::GFP::RAB-11, (I, J) Phyp7::mNeonGreen::RME-1, (M, N) Phyp7::mNeonGreen::LGG-1. The seam cell is labeled in all images. Red arrows (N) indicate instances of tubulation. (C–P) Indicated parameters corresponding to the left-hand panels are indicated. Dot plots show the mean and 95% CI. Statistical significance (C–O) was determined by an unpaired t-test or (P) Fisher’s exact test. ****p ≤ 0.0001; **p ≤ 0.01; ns, not significant. Raw data are available in S1 File.

(TIFF)

pgen.1011740.s006.tiff (15.7MB, tiff)
S7 Fig. Effects of piki-1(ok2346) deletion allele on PI(3)P and PI(4,5)P2.

(A) Enlarged image of RAB-5::mKate and 2xTAPP-1::mNeonGreen [PI(3,4)P2] markers showing protrusions and tubule-like structures (green) emanating from early endosomes (magenta). (B, C, E and F) Representative confocal images of wild-type and piki-1(ok2346) day-1 adults expressing (A, B) a PI(3)P lipid sensor [Phyp7::2xFYVE::mNeonGreen] and (D, E) a PI(4,5)P2 lipid sensor [Phyp7::PH PLC δ::mNeonGreen]. (D) Puncta per unit area for worms expressing Phyp7::2xFYVE::mNeonGreen were slightly decreased. (G) Mean intensity for worms expressing Phyp7::PH PLC δ::mNeonGreen was unchanged. Dot plots show the mean and 95% CI. Statistical significance was determined using unpaired t-tests; ****p ≤ 0.0001; ns, not significant. Raw data are available in S1 File.

(TIFF)

pgen.1011740.s007.tiff (20.9MB, tiff)
S8 Fig. Effects of PIKI-1 reduction of function on the multi-specific lipid sensor AKT-PH.

(A–C, E and F) Representative confocal images of day-1 adults expressing the PI(3,4)P2/PI(3,4,5)P3 lipid sensor Phyp7::AKT::oxGFP in (A) wild-type, (B and C) piki-1(Q1507Stop), or (E and F) piki-1(ok2346) backgrounds. White arrows (A) indicate nuclei. Orange arrows (B, E) indicate aggregations. Red arrows (C, F) indicate tubulations. (D, G) Individual worms expressing Phyp7::AKT-PH::oxGFP were scored for the presence of diffuse labeling, aggregations, or aggregations and tubulations within the epidermis. Statistical significance of the differences in phenotype distributions were determined using Chi-squared tests; ****p < 0.0001. Raw data are available in S1 File.

(TIFF)

pgen.1011740.s008.tiff (20.9MB, tiff)
S9 Fig. Effects of reduction of PIKI-1 function on lysosomal markers.

(A, B, D and E) Representative confocal images of day-1 adults expressing (A, B) Phyp7::LMP-1::mNeonGreen or (D, E) NUC-1::mCherry in (A, D) wild-type and (B, E) piki-1(Q1507Stop) backgrounds. (C) Mean intensity was plotted for Phyp7::LMP-1::mNeonGreen. (F) The number of puncta per unit area and (G) size of puncta were plotted for NUC-1::mCherry. Dot plots show the mean and 95% CI. Statistical significance was determined using unpaired t-tests; ****p ≤ 0.0001; ns, not significant. Raw data are available in S1 File.

(TIFF)

pgen.1011740.s009.tiff (20.9MB, tiff)
S10 Fig. Marker expression in worms homozygous for Phyp7::PIKI-1::mNeonGreen and Pdyp-7::mKate2::RAB-5.

(A–C) Representative raw images of a day-1 adult homozygous for both Phyp7::PIKI-1::mNeonGreen and Pdpy-7::mKate2::RAB-5. Both (A,B) single-channel and (C) merged images are shown. Note abnormal expression of PIKI-1 in the seam cell.

(TIFF)

pgen.1011740.s010.tiff (20.9MB, tiff)
S1 Movie. Pnekl-3::2xTAPP1::mNeonGreen in the epidermis of a wild-type worm.

z-Stack movie showing the expression of the PI(3,4)P2 sensor Pnekl-3::2xTAPP1::mNeonGreen from the apical to the basal plane in the epidermis of a wild-type worm.

(AVI)

Download video file (4.5MB, avi)
S2 Movie. Pnekl-3::2xTAPP1::mNeonGreen in the epidermis of a piki-1(Q1507Stop) worm.

z-Stack movie showing the expression of the PI(3,4)P2 sensor Pnekl-3::2xTAPP1::mNeonGreen from the apical to the basal plane in the epidermis of a piki-1(Q1507Stop) mutant.

(AVI)

Download video file (4.4MB, avi)
S1 File. Raw data for manuscripts figures.

Excel file with individual labeled tabs containing raw data for Figs 1–7, S1, and S3–S9. Data are labeled according to figure numbers and panels.

(XLSX)

pgen.1011740.s013.xlsx (138.6KB, xlsx)
S2 File. Supplemental Tables A-C.

Excel file with individual labeled tabs for Table A, strain list; Table B, RNAi sequences/reagents; and Table C, CRISPR sequences/reagents.

(XLSX)

pgen.1011740.s014.xlsx (15.7KB, xlsx)

Acknowledgments

The authors thank Amy Fluet for editing this manuscript and the three anonymous reviewers for their valuable input, which improved the manuscript. The authors also thank Zheng Zhou (Baylor College of Medicine) for the plasmid construct containing piki-1 cDNA and Reto Gassmann (University of Porto) for sharing GCP1474 (Pdpy7::mKate-2::rab-5) with us. Some strains were provided by the CGC, which was funded by the NIH Office of Research Infrastructure Programs (P40 OD010440). The authors acknowledge the Center for Advanced Scientific Instrumentation (CASI) at the University of Wyoming for access to spINBRE TIRF. This research was supported by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the NIH under Grant P20GM103432 and by NIH R35 GM136236 to DSF.

Data Availability

All relevant data are in the manuscript and its supporting information files.

Funding Statement

o This work was funded by National Institutes of Health (NIGMS) grants GM136236 and GM103432 to DSF and GM135326 to BDG. This included salary for DSF (GM136236 and GM103432), PTE (GM136236), GRR (GM136236), SC (GM136236), and BDG (GM135326). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Balla T. Phosphoinositides: tiny lipids with giant impact on cell regulation. Physiol Rev. 2013;93(3):1019–137. doi: 10.1152/physrev.00028.2012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Dickson EJ, Hille B. Understanding phosphoinositides: rare, dynamic, and essential membrane phospholipids. Biochem J. 2019;476(1):1–23. doi: 10.1042/BCJ20180022 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Falkenburger BH, Jensen JB, Dickson EJ, Suh B-C, Hille B. Phosphoinositides: lipid regulators of membrane proteins. J Physiol. 2010;588(Pt 17):3179–85. doi: 10.1113/jphysiol.2010.192153 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Haucke V, Di Paolo G. Lipids and lipid modifications in the regulation of membrane traffic. Curr Opin Cell Biol. 2007;19(4):426–35. doi: 10.1016/j.ceb.2007.06.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Posor Y, Jang W, Haucke V. Phosphoinositides as membrane organizers. Nat Rev Mol Cell Biol. 2022;23(12):797–816. doi: 10.1038/s41580-022-00490-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Di Paolo G, De Camilli P. Phosphoinositides in cell regulation and membrane dynamics. Nature. 2006;443(7112):651–7. doi: 10.1038/nature05185 [DOI] [PubMed] [Google Scholar]
  • 7.Marat AL, Haucke V. Phosphatidylinositol 3-phosphates-at the interface between cell signalling and membrane traffic. EMBO J. 2016;35(6):561–79. doi: 10.15252/embj.201593564 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Wenk MR, Lucast L, Di Paolo G, Romanelli AJ, Suchy SF, Nussbaum RL, et al. Phosphoinositide profiling in complex lipid mixtures using electrospray ionization mass spectrometry. Nat Biotechnol. 2003;21(7):813–7. doi: 10.1038/nbt837 [DOI] [PubMed] [Google Scholar]
  • 9.Prever L, Squillero G, Hirsch E, Gulluni F. Linking phosphoinositide function to mitosis. Cell Rep. 2024;43(6):114273. doi: 10.1016/j.celrep.2024.114273 [DOI] [PubMed] [Google Scholar]
  • 10.Bilanges B, Posor Y, Vanhaesebroeck B. PI3K isoforms in cell signalling and vesicle trafficking. Nat Rev Mol Cell Biol. 2019;20(9):515–34. doi: 10.1038/s41580-019-0129-z [DOI] [PubMed] [Google Scholar]
  • 11.Burke JE, Triscott J, Emerling BM, Hammond GRV. Beyond PI3Ks: targeting phosphoinositide kinases in disease. Nat Rev Drug Discov. 2023;22(5):357–86. doi: 10.1038/s41573-022-00582-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Jean S, Kiger AA. Classes of phosphoinositide 3-kinases at a glance. J Cell Sci. 2014;127(Pt 5):923–8. doi: 10.1242/jcs.093773 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Bilanges B, Alliouachene S, Pearce W, Morelli D, Szabadkai G, Chung Y-L, et al. Vps34 PI 3-kinase inactivation enhances insulin sensitivity through reprogramming of mitochondrial metabolism. Nat Commun. 2017;8(1):1804. doi: 10.1038/s41467-017-01969-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Walker EH, Perisic O, Ried C, Stephens L, Williams RL. Structural insights into phosphoinositide 3-kinase catalysis and signalling. Nature. 1999;402(6759):313–20. doi: 10.1038/46319 [DOI] [PubMed] [Google Scholar]
  • 15.Clark J, Anderson KE, Juvin V, Smith TS, Karpe F, Wakelam MJO, et al. Quantification of PtdInsP3 molecular species in cells and tissues by mass spectrometry. Nat Methods. 2011;8(3):267–72. doi: 10.1038/nmeth.1564 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Safaroghli-Azar A, Sanaei M-J, Pourbagheri-Sigaroodi A, Bashash D. Phosphoinositide 3-kinase (PI3K) classes: From cell signaling to endocytic recycling and autophagy. Eur J Pharmacol. 2023;953:175827. doi: 10.1016/j.ejphar.2023.175827 [DOI] [PubMed] [Google Scholar]
  • 17.Shepherd PR, Withers DJ, Siddle K. Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling. Biochem J. 1998;333(Pt 3):471–90. doi: 10.1042/bj3330471 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Thibault B, Ramos-Delgado F, Guillermet-Guibert J. Targeting Class I-II-III PI3Ks in Cancer Therapy: Recent Advances in Tumor Biology and Preclinical Research. Cancers (Basel). 2023;15(3):784. doi: 10.3390/cancers15030784 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Gulluni F, De Santis MC, Margaria JP, Martini M, Hirsch E. Class II PI3K Functions in Cell Biology and Disease. Trends Cell Biol. 2019;29(4):339–59. doi: 10.1016/j.tcb.2019.01.001 [DOI] [PubMed] [Google Scholar]
  • 20.Koch PA, Dornan GL, Hessenberger M, Haucke V. The molecular mechanisms mediating class II PI 3-kinase function in cell physiology. FEBS J. 2021;288(24):7025–42. doi: 10.1111/febs.15692 [DOI] [PubMed] [Google Scholar]
  • 21.Yoshioka K. Class II phosphatidylinositol 3-kinase isoforms in vesicular trafficking. Biochem Soc Trans. 2021;49(2):893–901. doi: 10.1042/BST20200835 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Simonsen A, Lippé R, Christoforidis S, Gaullier JM, Brech A, Callaghan J, et al. EEA1 links PI(3)K function to Rab5 regulation of endosome fusion. Nature. 1998;394(6692):494–8. doi: 10.1038/28879 [DOI] [PubMed] [Google Scholar]
  • 23.Hawkins PT, Stephens LR. Emerging evidence of signalling roles for PI(3,4)P2 in Class I and II PI3K-regulated pathways. Biochem Soc Trans. 2016;44(1):307–14. doi: 10.1042/BST20150248 [DOI] [PubMed] [Google Scholar]
  • 24.Marcelić M, Mahmutefendić Lučin H, Jurak Begonja A, Blagojević Zagorac G, Lučin P. Early Endosomal Vps34-Derived Phosphatidylinositol-3-Phosphate Is Indispensable for the Biogenesis of the Endosomal Recycling Compartment. Cells. 2022;11(6):962. doi: 10.3390/cells11060962 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Roggo L, Bernard V, Kovacs AL, Rose AM, Savoy F, Zetka M, et al. Membrane transport in Caenorhabditis elegans: an essential role for VPS34 at the nuclear membrane. EMBO J. 2002;21(7):1673–83. doi: 10.1093/emboj/21.7.1673 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Goulden BD, Pacheco J, Dull A, Zewe JP, Deiters A, Hammond GRV. A high-avidity biosensor reveals plasma membrane PI(3,4)P2 is predominantly a class I PI3K signaling product. J Cell Biol. 2019;218(3):1066–79. doi: 10.1083/jcb.201809026 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Gozzelino L, De Santis MC, Gulluni F, Hirsch E, Martini M. PI(3,4)P2 Signaling in Cancer and Metabolism. Front Oncol. 2020;10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Stephens LR, Jackson TR, Hawkins PT. Agonist-stimulated synthesis of phosphatidylinositol(3,4,5)-trisphosphate: a new intracellular signalling system? Biochim Biophys Acta. 1993;1179(1):27–75. doi: 10.1016/0167-4889(93)90072-w [DOI] [PubMed] [Google Scholar]
  • 29.Wang H, Loerke D, Bruns C, Müller R, Koch P-A, Puchkov D, et al. Phosphatidylinositol 3,4-bisphosphate synthesis and turnover are spatially segregated in the endocytic pathway. J Biol Chem. 2020;295(4):1091–104. doi: 10.1074/jbc.RA119.011774 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Watt SA, Kimber WA, Fleming IN, Leslie NR, Downes CP, Lucocq JM. Detection of novel intracellular agonist responsive pools of phosphatidylinositol 3,4-bisphosphate using the TAPP1 pleckstrin homology domain in immunoelectron microscopy. Biochem J. 2004;377(Pt 3):653–63. doi: 10.1042/BJ20031397 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Yudushkin I. TAPPing into PIPs: A new reporter reveals the origin of plasma membrane PI(3,4)P2. J Cell Biol. 2019;218(3):735–6. doi: 10.1083/jcb.201901143 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Lo W-T, Belabed H, Kücükdisli M, Metag J, Roske Y, Prokofeva P, et al. Development of selective inhibitors of phosphatidylinositol 3-kinase C2α. Nat Chem Biol. 2022;19(1):18–27. doi: 10.1038/s41589-022-01118-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Lo W-T, Zhang Y, Vadas O, Roske Y, Gulluni F, De Santis MC, et al. Structural basis of phosphatidylinositol 3-kinase C2α function. Nat Struct Mol Biol. 2022;29(3):218–28. doi: 10.1038/s41594-022-00730-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Misawa H, Ohtsubo M, Copeland NG, Gilbert DJ, Jenkins NA, Yoshimura A. Cloning and characterization of a novel class II phosphoinositide 3-kinase containing C2 domain. Biochem Biophys Res Commun. 1998;244(2):531–9. doi: 10.1006/bbrc.1998.8294 [DOI] [PubMed] [Google Scholar]
  • 35.Wang H, Lo W-T, Vujičić Žagar A, Gulluni F, Lehmann M, Scapozza L, et al. Autoregulation of Class II Alpha PI3K Activity by Its Lipid-Binding PX-C2 Domain Module. Mol Cell. 2018;71(2):343-351.e4. doi: 10.1016/j.molcel.2018.06.042 [DOI] [PubMed] [Google Scholar]
  • 36.Wheeler M, Domin J. The N-terminus of phosphoinositide 3-kinase-C2beta regulates lipid kinase activity and binding to clathrin. J Cell Physiol. 2006;206(3):586–93. doi: 10.1002/jcp.20507 [DOI] [PubMed] [Google Scholar]
  • 37.Fruman DA, Chiu H, Hopkins BD, Bagrodia S, Cantley LC, Abraham RT. The PI3K Pathway in Human Disease. Cell. 2017;170(4):605–35. doi: 10.1016/j.cell.2017.07.029 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Hawkins PT, Stephens LR. PI3K signalling in inflammation. Biochim Biophys Acta. 2015;1851(6):882–97. doi: 10.1016/j.bbalip.2014.12.006 [DOI] [PubMed] [Google Scholar]
  • 39.Redpath GMI, Betzler VM, Rossatti P, Rossy J. Membrane Heterogeneity Controls Cellular Endocytic Trafficking. Front Cell Dev Biol. 2020;8:757. doi: 10.3389/fcell.2020.00757 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Daste F, Walrant A, Holst MR, Gadsby JR, Mason J, Lee J-E, et al. Control of actin polymerization via the coincidence of phosphoinositides and high membrane curvature. J Cell Biol. 2017;216(11):3745–65. doi: 10.1083/jcb.201704061 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Gaidarov I, Smith ME, Domin J, Keen JH. The class II phosphoinositide 3-kinase C2alpha is activated by clathrin and regulates clathrin-mediated membrane trafficking. Mol Cell. 2001;7(2):443–9. doi: 10.1016/s1097-2765(01)00191-5 [DOI] [PubMed] [Google Scholar]
  • 42.Höning S, Ricotta D, Krauss M, Späte K, Spolaore B, Motley A, et al. Phosphatidylinositol-(4,5)-bisphosphate regulates sorting signal recognition by the clathrin-associated adaptor complex AP2. Mol Cell. 2005;18(5):519–31. doi: 10.1016/j.molcel.2005.04.019 [DOI] [PubMed] [Google Scholar]
  • 43.Mettlen M, Chen P-H, Srinivasan S, Danuser G, Schmid SL. Regulation of Clathrin-Mediated Endocytosis. Annu Rev Biochem. 2018;87:871–96. doi: 10.1146/annurev-biochem-062917-012644 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Beck KA, Keen JH. Interaction of phosphoinositide cycle intermediates with the plasma membrane-associated clathrin assembly protein AP-2. J Biol Chem. 1991;266(7):4442–7. doi: 10.1016/s0021-9258(20)64342-3 [DOI] [PubMed] [Google Scholar]
  • 45.Rohde G, Wenzel D, Haucke V. A phosphatidylinositol (4,5)-bisphosphate binding site within mu2-adaptin regulates clathrin-mediated endocytosis. J Cell Biol. 2002;158(2):209–14. doi: 10.1083/jcb.200203103 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Chandra M, Collins BM. The Phox Homology (PX) Domain. Adv Exp Med Biol. 2019;1111:1–17. doi: 10.1007/5584_2018_185 [DOI] [PubMed] [Google Scholar]
  • 47.Jovic M, Sharma M, Rahajeng J, Caplan S. The early endosome: a busy sorting station for proteins at the crossroads. Histol Histopathol. 2010;25(1):99–112. doi: 10.14670/HH-25.99 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Naslavsky N, Caplan S. The enigmatic endosome - sorting the ins and outs of endocytic trafficking. J Cell Sci. 2018;131(13):jcs216499. doi: 10.1242/jcs.216499 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Wallroth A, Haucke V. Phosphoinositide conversion in endocytosis and the endolysosomal system. J Biol Chem. 2018;293(5):1526–35. doi: 10.1074/jbc.R117.000629 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Singla A, Fedoseienko A, Giridharan SSP, Overlee BL, Lopez A, Jia D, et al. Endosomal PI(3)P regulation by the COMMD/CCDC22/CCDC93 (CCC) complex controls membrane protein recycling. Nat Commun. 2019;10(1):4271. doi: 10.1038/s41467-019-12221-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Simonsen A, Lippé R, Christoforidis S, Gaullier JM, Brech A, Callaghan J, et al. EEA1 links PI(3)K function to Rab5 regulation of endosome fusion. Nature. 1998;394(6692):494–8. doi: 10.1038/28879 [DOI] [PubMed] [Google Scholar]
  • 52.Christoforidis S, McBride HM, Burgoyne RD, Zerial M. The Rab5 effector EEA1 is a core component of endosome docking. Nature. 1999;397(6720):621–5. doi: 10.1038/17618 [DOI] [PubMed] [Google Scholar]
  • 53.Odorizzi G, Babst M, Emr SD. Fab1p PtdIns(3)P 5-kinase function essential for protein sorting in the multivesicular body. Cell. 1998;95(6):847–58. doi: 10.1016/s0092-8674(00)81707-9 [DOI] [PubMed] [Google Scholar]
  • 54.Whitley P, Reaves BJ, Hashimoto M, Riley AM, Potter BVL, Holman GD. Identification of mammalian Vps24p as an effector of phosphatidylinositol 3,5-bisphosphate-dependent endosome compartmentalization. J Biol Chem. 2003;278(40):38786–95. doi: 10.1074/jbc.M306864200 [DOI] [PubMed] [Google Scholar]
  • 55.Campa CC, Hirsch E. Rab11 and phosphoinositides: A synergy of signal transducers in the control of vesicular trafficking. Adv Biol Regul. 2017;63:132–9. doi: 10.1016/j.jbior.2016.09.002 [DOI] [PubMed] [Google Scholar]
  • 56.Franco I, Gulluni F, Campa CC, Costa C, Margaria JP, Ciraolo E, et al. PI3K class II α controls spatially restricted endosomal PtdIns3P and Rab11 activation to promote primary cilium function. Dev Cell. 2014;28(6):647–58. doi: 10.1016/j.devcel.2014.01.022 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.He K, Marsland R III, Upadhyayula S, Song E, Dang S, Capraro BR, et al. Dynamics of phosphoinositide conversion in clathrin-mediated endocytic traffic. Nature. 2017;552(7685):410–4. doi: 10.1038/nature25146 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Román-Fernández Á, Roignot J, Sandilands E, Nacke M, Mansour MA, McGarry L, et al. The phospholipid PI(3,4)P2 is an apical identity determinant. Nat Commun. 2018;9(1):5041. doi: 10.1038/s41467-018-07464-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Feng Z, Yu C-H. PI(3,4)P2-mediated membrane tubulation promotes integrin trafficking and invasive cell migration. Proc Natl Acad Sci U S A. 2021;118(19):e2017645118. doi: 10.1073/pnas.2017645118 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Feng Z, Yu C-H. PI(3,4)P2-mediated membrane tubulation promotes integrin trafficking and invasive cell migration. Proc Natl Acad Sci U S A. 2021;118(19):e2017645118. doi: 10.1073/pnas.2017645118 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Malek M, Kielkowska A, Chessa T, Anderson KE, Barneda D, Pir P, et al. PTEN Regulates PI(3,4)P2 Signaling Downstream of Class I PI3K. Mol Cell. 2017;68(3):566-580.e10. doi: 10.1016/j.molcel.2017.09.024 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Balla T. Imaging and manipulating phosphoinositides in living cells. J Physiol. 2007;582(Pt 3):927–37. doi: 10.1113/jphysiol.2007.132795 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Nasuhoglu C, Feng S, Mao J, Yamamoto M, Yin HL, Earnest S, et al. Nonradioactive analysis of phosphatidylinositides and other anionic phospholipids by anion-exchange high-performance liquid chromatography with suppressed conductivity detection. Anal Biochem. 2002;301(2):243–54. doi: 10.1006/abio.2001.5489 [DOI] [PubMed] [Google Scholar]
  • 64.Balla T, Várnai P. Visualization of cellular phosphoinositide pools with GFP-fused protein-domains. Curr Protoc Cell Biol. 2009;Chapter 24:Unit 24.4. doi: 10.1002/0471143030.cb2404s42 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Falasca M, Hamilton JR, Selvadurai M, Sundaram K, Adamska A, Thompson PE. Class II Phosphoinositide 3-Kinases as Novel Drug Targets. J Med Chem. 2017;60(1):47–65. doi: 10.1021/acs.jmedchem.6b00963 [DOI] [PubMed] [Google Scholar]
  • 66.Naslavsky N, Caplan S. Advances and challenges in understanding endosomal sorting and fission. FEBS J. 2023;290(17):4187–95. doi: 10.1111/febs.16687 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Norris A, Grant BD. Endosomal microdomains: Formation and function. Curr Opin Cell Biol. 2020;65:86–95. doi: 10.1016/j.ceb.2020.02.018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Kalasova I, Fáberová V, Kalendová A, Yildirim S, Uličná L, Venit T, et al. Tools for visualization of phosphoinositides in the cell nucleus. Histochem Cell Biol. 2016;145(4):485–96. doi: 10.1007/s00418-016-1409-8 [DOI] [PubMed] [Google Scholar]
  • 69.Hammond GRV, Ricci MMC, Weckerly CC, Wills RC. An update on genetically encoded lipid biosensors. Mol Biol Cell. 2022;33(5):tp2. doi: 10.1091/mbc.E21-07-0363 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Lemmon MA. Membrane recognition by phospholipid-binding domains. Nat Rev Mol Cell Biol. 2008;9(2):99–111. doi: 10.1038/nrm2328 [DOI] [PubMed] [Google Scholar]
  • 71.Wills RC, Goulden BD, Hammond GRV. Genetically encoded lipid biosensors. Mol Biol Cell. 2018;29(13):1526–32. doi: 10.1091/mbc.E17-12-0738 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Sato K, Norris A, Sato M, Grant BD. C. elegans as a model for membrane traffic. WormBook: The Online Review of C elegans Biology. 2018. Available from: http://www.wormbook.org [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Lažetić V, Fay DS. Molting in C. elegans. Worm. 2017;6(1):e1330246. doi: 10.1080/21624054.2017.1330246 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Joseph BB, Naslavsky N, Binti S, Conquest S, Robison L, Bai G, et al. Conserved NIMA kinases regulate multiple steps of endocytic trafficking. PLoS Genet. 2023;19(4):e1010741. doi: 10.1371/journal.pgen.1010741 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Joseph BB, Wang Y, Edeen P, Lažetić V, Grant BD, Fay DS. Control of clathrin-mediated endocytosis by NIMA family kinases. PLoS Genet. 2020;16(2):e1008633. doi: 10.1371/journal.pgen.1008633 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Lažetić V, Fay DS. Conserved Ankyrin Repeat Proteins and Their NIMA Kinase Partners Regulate Extracellular Matrix Remodeling and Intracellular Trafficking in Caenorhabditis elegans. Genetics. 2017;205(1):273–93. doi: 10.1534/genetics.116.194464 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Yochem J, Lažetić V, Bell L, Chen L, Fay D. C. elegans NIMA-related kinases NEKL-2 and NEKL-3 are required for the completion of molting. Dev Biol. 2015;398(2):255–66. doi: 10.1016/j.ydbio.2014.12.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Lažetić V, Joseph BB, Bernazzani SM, Fay DS. Actin organization and endocytic trafficking are controlled by a network linking NIMA-related kinases to the CDC-42-SID-3/ACK1 pathway. PLoS Genet. 2018;14(4):e1007313. doi: 10.1371/journal.pgen.1007313 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Milne SM, Edeen PT, Fay DS. TAT-1, a phosphatidylserine flippase, affects molting and regulates membrane trafficking in the epidermis of Caenorhabditis elegans. Genetics. 2025;229(3):iyae216. doi: 10.1093/genetics/iyae216 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Joseph BB, Blouin NA, Fay DS. Use of a Sibling Subtraction Method for Identifying Causal Mutations in Caenorhabditis elegans by Whole-Genome Sequencing. G3 (Bethesda). 2018;8(2):669–78. doi: 10.1534/g3.117.300135 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Chen K-E, Tillu VA, Chandra M, Collins BM. Molecular Basis for Membrane Recruitment by the PX and C2 Domains of Class II Phosphoinositide 3-Kinase-C2α. Structure. 2018;26(12):1612-1625.e4. doi: 10.1016/j.str.2018.08.010 [DOI] [PubMed] [Google Scholar]
  • 82.Hug N, Longman D, Cáceres JF. Mechanism and regulation of the nonsense-mediated decay pathway. Nucleic Acids Res. 2016;44(4):1483–95. doi: 10.1093/nar/gkw010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.C. elegans Deletion Mutant Consortium. large-scale screening for targeted knockouts in the Caenorhabditis elegans genome. G3 (Bethesda). 2012;2(11):1415–25. doi: 10.1534/g3.112.003830 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Bharill P, Ayyadevara S, Alla R, Shmookler Reis RJ. Extreme Depletion of PIP3 Accompanies the Increased Life Span and Stress Tolerance of PI3K-null C. elegans Mutants. Front Genet. 2013;4:34. doi: 10.3389/fgene.2013.00034 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Gil EB, Malone Link E, Liu LX, Johnson CD, Lees JA. Regulation of the insulin-like developmental pathway of Caenorhabditis elegans by a homolog of the PTEN tumor suppressor gene. Proc Natl Acad Sci U S A. 1999;96(6):2925–30. doi: 10.1073/pnas.96.6.2925 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Aung KT, Yoshioka K, Aki S, Ishimaru K, Takuwa N, Takuwa Y. The class II phosphoinositide 3-kinases PI3K-C2α and PI3K-C2β differentially regulate clathrin-dependent pinocytosis in human vascular endothelial cells. J Physiol Sci. 2019;69(2):263–80. doi: 10.1007/s12576-018-0644-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Domin J, Gaidarov I, Smith ME, Keen JH, Waterfield MD. The class II phosphoinositide 3-kinase PI3K-C2alpha is concentrated in the trans-Golgi network and present in clathrin-coated vesicles. J Biol Chem. 2000;275(16):11943–50. doi: 10.1074/jbc.275.16.11943 [DOI] [PubMed] [Google Scholar]
  • 88.Cheng S, Wang K, Zou W, Miao R, Huang Y, Wang H, et al. PtdIns(4,5)P₂ and PtdIns3P coordinate to regulate phagosomal sealing for apoptotic cell clearance. J Cell Biol. 2015;210(3):485–502. doi: 10.1083/jcb.201501038 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Cheng S, Wu Y, Lu Q, Yan J, Zhang H, Wang X. Autophagy genes coordinate with the class II PI/PtdIns 3-kinase PIKI-1 to regulate apoptotic cell clearance in C. elegans. Autophagy. 2013;9(12):2022–32. doi: 10.4161/auto.26323 [DOI] [PubMed] [Google Scholar]
  • 90.Liu J, Li M, Li L, Chen S, Wang X. Ubiquitination of the PI3-kinase VPS-34 promotes VPS-34 stability and phagosome maturation. J Cell Biol. 2018;217(1):347–60. doi: 10.1083/jcb.201705116 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91.Zou W, Lu Q, Zhao D, Li W, Mapes J, Xie Y, et al. Caenorhabditis elegans myotubularin MTM-1 negatively regulates the engulfment of apoptotic cells. PLoS Genet. 2009;5(10):e1000679. doi: 10.1371/journal.pgen.1000679 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Lu N, Shen Q, Mahoney TR, Neukomm LJ, Wang Y, Zhou Z. Two PI 3-kinases and one PI 3-phosphatase together establish the cyclic waves of phagosomal PtdIns(3)P critical for the degradation of apoptotic cells. PLoS Biol. 2012;10(1):e1001245. doi: 10.1371/journal.pbio.1001245 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93.Clancy JC, Vo AA, Myles KM, Levenson MT, Ragle JM, Ward JD. Experimental considerations for study of C. elegans lysosomal proteins. G3 (Bethesda). 2023;13(4):jkad032. doi: 10.1093/g3journal/jkad032 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94.Frøkjær-Jensen C, Davis MW, Sarov M, Taylor J, Flibotte S, LaBella M, et al. Random and targeted transgene insertion in Caenorhabditis elegans using a modified Mos1 transposon. Nat Methods. 2014;11(5):529–34. doi: 10.1038/nmeth.2889 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.Ghaddar A, Armingol E, Huynh C, Gevirtzman L, Lewis NE, Waterston R, et al. Whole-body gene expression atlas of an adult metazoan. Sci Adv. 2023;9(25):eadg0506. doi: 10.1126/sciadv.adg0506 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.Grove C, Cain S, Chen WJ, Davis P, Harris T, Howe KL, et al. Using WormBase: A Genome Biology Resource for Caenorhabditis elegans and Related Nematodes. Methods Mol Biol. 2018;1757:399–470. doi: 10.1007/978-1-4939-7737-6_14 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.Stenmark H. Rab GTPases as coordinators of vesicle traffic. Nat Rev Mol Cell Biol. 2009;10(8):513–25. doi: 10.1038/nrm2728 [DOI] [PubMed] [Google Scholar]
  • 98.Miao R, Li M, Zhang Q, Yang C, Wang X. An ECM-to-Nucleus Signaling Pathway Activates Lysosomes for C. elegans Larval Development. Dev Cell. 2020;52(1). doi: 10.1016/j.devcel.2019.10.020 [DOI] [PubMed] [Google Scholar]
  • 99.Levin-Konigsberg R, Montaño-Rendón F, Keren-Kaplan T, Li R, Ego B, Mylvaganam S, et al. Phagolysosome resolution requires contacts with the endoplasmic reticulum and phosphatidylinositol-4-phosphate signalling. Nat Cell Biol. 2019;21(10):1234–47. doi: 10.1038/s41556-019-0394-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100.Vonderheit A, Helenius A. Rab7 associates with early endosomes to mediate sorting and transport of Semliki forest virus to late endosomes. PLoS Biol. 2005;3(7):e233. doi: 10.1371/journal.pbio.0030233 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101.Rink J, Ghigo E, Kalaidzidis Y, Zerial M. Rab conversion as a mechanism of progression from early to late endosomes. Cell. 2005;122(5):735–49. doi: 10.1016/j.cell.2005.06.043 [DOI] [PubMed] [Google Scholar]
  • 102.Skjeldal FM, Haugen LH, Mateus D, Frei DM, Rødseth AV, Hu X, et al. De novo formation of early endosomes during Rab5-to-Rab7a transition. J Cell Sci. 2021;134(8):jcs254185. doi: 10.1242/jcs.254185 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 103.Shearer LJ, Petersen NO. Distribution and Co-localization of endosome markers in cells. Heliyon. 2019;5(9):e02375. doi: 10.1016/j.heliyon.2019.e02375 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 104.Posor Y, Eichhorn-Gruenig M, Puchkov D, Schöneberg J, Ullrich A, Lampe A, et al. Spatiotemporal control of endocytosis by phosphatidylinositol-3,4-bisphosphate. Nature. 2013;499(7457):233–7. doi: 10.1038/nature12360 [DOI] [PubMed] [Google Scholar]
  • 105.Yochem J, Tuck S, Greenwald I, Han M. A gp330/megalin-related protein is required in the major epidermis of Caenorhabditis elegans for completion of molting. Development. 1999;126(3):597–606. doi: 10.1242/dev.126.3.597 [DOI] [PubMed] [Google Scholar]
  • 106.Carlton JG, Bujny MV, Peter BJ, Oorschot VMJ, Rutherford A, Arkell RS, et al. Sorting nexin-2 is associated with tubular elements of the early endosome, but is not essential for retromer-mediated endosome-to-TGN transport. J Cell Sci. 2005;118(Pt 19):4527–39. doi: 10.1242/jcs.02568 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 107.Cozier GE, Carlton J, McGregor AH, Gleeson PA, Teasdale RD, Mellor H, et al. The phox homology (PX) domain-dependent, 3-phosphoinositide-mediated association of sorting nexin-1 with an early sorting endosomal compartment is required for its ability to regulate epidermal growth factor receptor degradation. J Biol Chem. 2002;277(50):48730–6. doi: 10.1074/jbc.M206986200 [DOI] [PubMed] [Google Scholar]
  • 108.Da Graça J, Morel E. Canonical and Non-Canonical Roles of SNX1 and SNX2 in Endosomal Membrane Dynamics. Contact (Thousand Oaks). 2023;6:25152564231217867. doi: 10.1177/25152564231217867 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 109.Seaman MN, McCaffery JM, Emr SD. A membrane coat complex essential for endosome-to-Golgi retrograde transport in yeast. J Cell Biol. 1998;142(3):665–81. doi: 10.1083/jcb.142.3.665 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 110.Carlton J, Bujny M, Peter BJ, Oorschot VMJ, Rutherford A, Mellor H, et al. Sorting nexin-1 mediates tubular endosome-to-TGN transport through coincidence sensing of high- curvature membranes and 3-phosphoinositides. Curr Biol. 2004;14(20):1791–800. doi: 10.1016/j.cub.2004.09.077 [DOI] [PubMed] [Google Scholar]
  • 111.Shi A, Sun L, Banerjee R, Tobin M, Zhang Y, Grant BD. Regulation of endosomal clathrin and retromer-mediated endosome to Golgi retrograde transport by the J-domain protein RME-8. EMBO J. 2009;28(21):3290–302. doi: 10.1038/emboj.2009.272 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 112.Gullapalli A, Garrett TA, Paing MM, Griffin CT, Yang Y, Trejo J. A role for sorting nexin 2 in epidermal growth factor receptor down-regulation: evidence for distinct functions of sorting nexin 1 and 2 in protein trafficking. Mol Biol Cell. 2004;15(5):2143–55. doi: 10.1091/mbc.e03-09-0711 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 113.Zhong Q, Lazar CS, Tronchère H, Sato T, Meerloo T, Yeo M, et al. Endosomal localization and function of sorting nexin 1. Proc Natl Acad Sci U S A. 2002;99(10):6767–72. doi: 10.1073/pnas.092142699 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 114.Norris A, Tammineni P, Wang S, Gerdes J, Murr A, Kwan KY, et al. SNX-1 and RME-8 oppose the assembly of HGRS-1/ESCRT-0 degradative microdomains on endosomes. Proc Natl Acad Sci U S A. 2017;114(3):E307–16. doi: 10.1073/pnas.1612730114 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 115.Shiwarski DJ, Darr M, Telmer CA, Bruchez MP, Puthenveedu MA. PI3K class II α regulates δ-opioid receptor export from the trans-Golgi network. Mol Biol Cell. 2017;28(16):2202–19. doi: 10.1091/mbc.E17-01-0030 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 116.Ghosh RN, Mallet WG, Soe TT, McGraw TE, Maxfield FR. An endocytosed TGN38 chimeric protein is delivered to the TGN after trafficking through the endocytic recycling compartment in CHO cells. J Cell Biol. 1998;142(4):923–36. doi: 10.1083/jcb.142.4.923 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 117.Roquemore EP, Banting G. Efficient trafficking of TGN38 from the endosome to the trans-Golgi network requires a free hydroxyl group at position 331 in the cytosolic domain. Mol Biol Cell. 1998;9(8):2125–44. doi: 10.1091/mbc.9.8.2125 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 118.Paschinger K, Hackl M, Gutternigg M, Kretschmer-Lubich D, Stemmer U, Jantsch V, et al. A deletion in the golgi alpha-mannosidase II gene of Caenorhabditis elegans results in unexpected non-wild-type N-glycan structures. J Biol Chem. 2006;281(38):28265–77. doi: 10.1074/jbc.M602878200 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 119.Igdoura SA, Herscovics A, Lal A, Moremen KW, Morales CR, Hermo L. Alpha-mannosidases involved in N-glycan processing show cell specificity and distinct subcompartmentalization within the Golgi apparatus of cells in the testis and epididymis. Eur J Cell Biol. 1999;78(7):441–52. doi: 10.1016/s0171-9335(99)80071-5 [DOI] [PubMed] [Google Scholar]
  • 120.Velasco A, Hendricks L, Moremen KW, Tulsiani DR, Touster O, Farquhar MG. Cell type-dependent variations in the subcellular distribution of alpha-mannosidase I and II. J Cell Biol. 1993;122(1):39–51. doi: 10.1083/jcb.122.1.39 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 121.Palmisano NJ, Meléndez A. Detection of Autophagy in Caenorhabditis elegans Using GFP::LGG-1 as an Autophagy Marker. Cold Spring Harb Protoc. 2016;2016(1):pdb.prot086496. doi: 10.1101/pdb.prot086496 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 122.Li W, Zou W, Yang Y, Chai Y, Chen B, Cheng S, et al. Autophagy genes function sequentially to promote apoptotic cell corpse degradation in the engulfing cell. J Cell Biol. 2012;197(1):27–35. doi: 10.1083/jcb.201111053 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 123.Zhang H, Chang JT, Guo B, Hansen M, Jia K, Kovács AL, et al. Guidelines for monitoring autophagy in Caenorhabditis elegans. Autophagy. 2015;11(1):9–27. doi: 10.1080/15548627.2014.1003478 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 124.Zhang Y, Yan L, Zhou Z, Yang P, Tian E, Zhang K, et al. SEPA-1 mediates the specific recognition and degradation of P granule components by autophagy in C. elegans. Cell. 2009;136(2):308–21. doi: 10.1016/j.cell.2008.12.022 [DOI] [PubMed] [Google Scholar]
  • 125.Philipp TM, Gong W, Köhnlein K, Ohse VA, Müller FI, Priebs J, et al. SEMO-1, a novel methanethiol oxidase in Caenorhabditis elegans, is a pro-aging factor conferring selective stress resistance. Biofactors. 2022;48(3):699–706. doi: 10.1002/biof.1836 [DOI] [PubMed] [Google Scholar]
  • 126.Wang Y, Arnold ML, Smart AJ, Wang G, Androwski RJ, Morera A, et al. Large vesicle extrusions from C. elegans neurons are consumed and stimulated by glial-like phagocytosis activity of the neighboring cell. Elife. 2023;12:e82227. doi: 10.7554/eLife.82227 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 127.Gillooly DJ, Morrow IC, Lindsay M, Gould R, Bryant NJ, Gaullier JM, et al. Localization of phosphatidylinositol 3-phosphate in yeast and mammalian cells. EMBO J. 2000;19(17):4577–88. doi: 10.1093/emboj/19.17.4577 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 128.Carvalho C, Moreira M, Barbosa DJ, Chan F-Y, Koehnen CB, Teixeira V, et al. ZYG-12/Hook’s dual role as a dynein adaptor for early endosomes and nuclei is regulated by alternative splicing of its cargo binding domain. Mol Biol Cell. 2025;36(2):ar19. doi: 10.1091/mbc.E24-08-0364 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 129.Lemmon MA. Phosphoinositide recognition domains. Traffic. 2003;4(4):201–13. doi: 10.1034/j.1600-0854.2004.00071.x [DOI] [PubMed] [Google Scholar]
  • 130.Maekawa M, Fairn GD. Molecular probes to visualize the location, organization and dynamics of lipids. J Cell Sci. 2014;127(Pt 22):4801–12. doi: 10.1242/jcs.150524 [DOI] [PubMed] [Google Scholar]
  • 131.Lolicato F, Nickel W, Haucke V, Ebner M. Phosphoinositide switches in cell physiology - From molecular mechanisms to disease. J Biol Chem. 2024;300(3):105757. doi: 10.1016/j.jbc.2024.105757 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 132.Yang Y, Lee M, Fairn GD. Phospholipid subcellular localization and dynamics. J Biol Chem. 2018;293(17):6230–40. doi: 10.1074/jbc.R117.000582 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 133.Aggad D, Brouilly N, Omi S, Essmann CL, Dehapiot B, Savage-Dunn C, et al. Meisosomes, folded membrane microdomains between the apical extracellular matrix and epidermis. Elife. 2023;12:e75906. doi: 10.7554/eLife.75906 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 134.Hammond GRV, Fischer MJ, Anderson KE, Holdich J, Koteci A, Balla T, et al. PI4P and PI(4,5)P2 are essential but independent lipid determinants of membrane identity. Science. 2012;337(6095):727–30. doi: 10.1126/science.1222483 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 135.Cockcroft S. The expanding roles of PI4P and PI(4,5)P2 at the plasma membrane: Role of phosphatidylinositol transfer proteins. Biochim Biophys Acta Mol Cell Biol Lipids. 2024;1869(2):159394. doi: 10.1016/j.bbalip.2023.159394 [DOI] [PubMed] [Google Scholar]
  • 136.Mesmin B, Bigay J, Polidori J, Jamecna D, Lacas-Gervais S, Antonny B. Sterol transfer, PI4P consumption, and control of membrane lipid order by endogenous OSBP. EMBO J. 2017;36(21):3156–74. doi: 10.15252/embj.201796687 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 137.Tan J, Brill JA. Cinderella story: PI4P goes from precursor to key signaling molecule. Crit Rev Biochem Mol Biol. 2014;49(1):33–58. doi: 10.3109/10409238.2013.853024 [DOI] [PubMed] [Google Scholar]
  • 138.Nakatsu F, Baskin JM, Chung J, Tanner LB, Shui G, Lee SY, et al. PtdIns4P synthesis by PI4KIIIα at the plasma membrane and its impact on plasma membrane identity. J Cell Biol. 2012;199(6):1003–16. doi: 10.1083/jcb.201206095 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 139.Bae Y-K, Kim E, L’hernault SW, Barr MM. The CIL-1 PI 5-phosphatase localizes TRP Polycystins to cilia and activates sperm in C. elegans. Curr Biol. 2009;19(19):1599–607. doi: 10.1016/j.cub.2009.08.045 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 140.Li Y, Chen B, Zou W, Wang X, Wu Y, Zhao D, et al. The lysosomal membrane protein SCAV-3 maintains lysosome integrity and adult longevity. J Cell Biol. 2016;215(2):167–85. doi: 10.1083/jcb.201602090 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 141.Hermann GJ, Schroeder LK, Hieb CA, Kershner AM, Rabbitts BM, Fonarev P, et al. Genetic analysis of lysosomal trafficking in Caenorhabditis elegans. Mol Biol Cell. 2005;16(7):3273–88. doi: 10.1091/mbc.e05-01-0060 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 142.Miehe S, Bieberstein A, Arnould I, Ihdene O, Rütten H, Strübing C. The phospholipid-binding protein SESTD1 is a novel regulator of the transient receptor potential channels TRPC4 and TRPC5. J Biol Chem. 2010;285(16):12426–34. doi: 10.1074/jbc.M109.068304 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 143.Jiang H, Sandoval Del Prado LE, Leung C, Wang D. Huntingtin-interacting protein family members have a conserved pro-viral function from Caenorhabditis elegans to humans. Proc Natl Acad Sci U S A. 2020;117(36):22462–72. doi: 10.1073/pnas.2006914117 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 144.Bannunah A, Cavanagh R, Shubber S, Vllasaliu D, Stolnik S. Difference in Endocytosis Pathways Used by Differentiated Versus Nondifferentiated Epithelial Caco-2 Cells to Internalize Nanosized Particles. Mol Pharm. 2024;21(7):3603–12. doi: 10.1021/acs.molpharmaceut.4c00333 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 145.Johnson A. Mechanistic divergences of endocytic clathrin-coated vesicle formation in mammals, yeasts and plants. J Cell Sci. 2024;137(16):jcs261847. doi: 10.1242/jcs.261847 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 146.Binti S, Edeen PT, Fay DS. Loss of the Na+/K+ cation pump CATP-1 suppresses nekl-associated molting defects. G3 (Bethesda). 2024;14(12):jkae244. doi: 10.1093/g3journal/jkae244 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 147.Binti S, Melinda RV, Joseph BB, Edeen PT, Miller SD, Fay DS. A life cycle alteration can correct molting defects in Caenorhabditis elegans. Dev Biol. 2022;483:143–56. doi: 10.1016/j.ydbio.2022.01.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 148.Binti S, Linder AG, Edeen PT, Fay DS. A conserved protein tyrosine phosphatase, PTPN-22, functions in diverse developmental processes in C. elegans. PLoS Genet. 2024;20(8):e1011219. doi: 10.1371/journal.pgen.1011219 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 149.Fay DS, Balasubramaniam B, Harrington SM, Eden PT. Proximity Labeling of NIMA Kinase Complex Components in C. elegans. bioRxiv. 2025;2025.06.16.659960. doi: 10.1101/2025.06.16.659960 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 150.Stiernagle T. Maintenance of C. elegans. WormBook. 2006;1–11. doi: 10.1895/wormbook.1.101.1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 151.Montgomery MK. The use of double-stranded RNA to knock down specific gene activity. In: Miller WJ, Capy P, editors. Mobile genetic elements: protocols and genomic applications. Totowa (NJ): Humana Press; 2004. p. 129–44. [DOI] [PubMed] [Google Scholar]
  • 152.Farboud B, Meyer BJ. Dramatic enhancement of genome editing by CRISPR/Cas9 through improved guide RNA design. Genetics. 2015;199(4):959–71. doi: 10.1534/genetics.115.175166 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 153.Farboud B, Severson AF, Meyer BJ. Strategies for Efficient Genome Editing Using CRISPR-Cas9. Genetics. 2019;211(2):431–57. doi: 10.1534/genetics.118.301775 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 154.Ghanta KS, Ishidate T, Mello CC. Microinjection for precision genome editing in Caenorhabditis elegans. STAR Protoc. 2021;2(3):100748. doi: 10.1016/j.xpro.2021.100748 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 155.Fay SF, Fay DS, Chhatre VE. CRISPRcruncher: A tool for engineering restriction sites into coding regions. MicroPubl Biol. 2021;2021:10.17912/micropub.biology.000343. doi: 10.17912/micropub.biology.000343 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 156.Redemann S, Schloissnig S, Ernst S, Pozniakowsky A, Ayloo S, Hyman AA, et al. Codon adaptation-based control of protein expression in C. elegans. Nat Methods. 2011;8(3):250–2. doi: 10.1038/nmeth.1565 [DOI] [PubMed] [Google Scholar]
  • 157.Várnai P, Balla T. Visualization of phosphoinositides that bind pleckstrin homology domains: calcium- and agonist-induced dynamic changes and relationship to myo-[3H]inositol-labeled phosphoinositide pools. J Cell Biol. 1998;143(2):501–10. doi: 10.1083/jcb.143.2.501 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 158.Zhang L, Ward JD, Cheng Z, Dernburg AF. The auxin-inducible degradation (AID) system enables versatile conditional protein depletion in C. elegans. Development. 2015;142(24):4374–84. doi: 10.1242/dev.129635 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 159.Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9(7):676–82. doi: 10.1038/nmeth.2019 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 160.Bolte S, Cordelières FP. A guided tour into subcellular colocalization analysis in light microscopy. J Microsc. 2006;224(Pt 3):213–32. doi: 10.1111/j.1365-2818.2006.01706.x [DOI] [PubMed] [Google Scholar]
  • 161.Dunn KW, Kamocka MM, McDonald JH. A practical guide to evaluating colocalization in biological microscopy. Am J Physiol Cell Physiol. 2011;300(4):C723-42. doi: 10.1152/ajpcell.00462.2010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 162.Fay DS, Gerow K. A biologist’s guide to statistical thinking and analysis. WormBook. 2013;:1–54. doi: 10.1895/wormbook.1.159.1 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Pablo Wappner

11 Jul 2025

PGENETICS-D-25-00615

PIKI-1, a class II phosphatidylinositol 3-kinase, functions in endocytic trafficking

PLOS Genetics

Dear Dr. David S. Fay,

Thank you for submitting your manuscript to PLOS Genetics. We apologise for the delay in the revision process due to the late receipt of the latest review. After careful consideration, we feel that it has merit but does not fully meet PLOS Genetics's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript within 60 days. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosgenetics@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pgenetics/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

* A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. This file does not need to include responses to formatting updates and technical items listed in the 'Journal Requirements' section below.

* A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

* An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, competing interests statement, or data availability statement, please make these updates within the submission form at the time of resubmission. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

We look forward to receiving your revised manuscript.

Kind regards,

Nathalie Pujol

Academic Editor

PLOS Genetics

Nathalie Pujol

Academic Editor

PLOS Genetics

Aimée Dudley

Editor-in-Chief

PLOS Genetics

Anne Goriely

Editor-in-Chief

PLOS Genetics

Additional Editor Comments:

additional minor comment: Could the authors comment on the ‘ectopic’ signal appearing in the seam of fig. S7? Is it related in any way to the signal in the seam in fig. 5H?

Journal Requirements:

1) Please ensure that the CRediT author contributions listed for every co-author are completed accurately and in full.

At this stage, the following Authors/Authors require contributions: Philip T. Edeen, Sylvia Conquest, Barth D. Grant, and David S. Fay. Please ensure that the full contributions of each author are acknowledged in the "Add/Edit/Remove Authors" section of our submission form.

The list of CRediT author contributions may be found here: https://journals.plos.org/plosgenetics/s/authorship#loc-author-contributions

2) We ask that a manuscript source file is provided at Revision. Please upload your manuscript file as a .doc, .docx, .rtf or .tex. If you are providing a .tex file, please upload it under the item type u2018LaTeX Source Fileu2019 and leave your .pdf version as the item type u2018Manuscriptu2019.

3) Please upload all main figures as separate Figure files in .tif or .eps format. For more information about how to convert and format your figure files please see our guidelines:

https://journals.plos.org/plosgenetics/s/figures

4) We notice that your supplementary Figures are included in the manuscript file. Please remove them and upload them with the file type 'Supporting Information'. Please ensure that each Supporting Information file has a legend listed in the manuscript after the references list.

5) We note that your Data Availability Statement is currently as follows: "All data is available in the supplementary files or available upon request.". Please confirm at this time whether or not your submission contains all raw data required to replicate the results of your study. Authors must share the “minimal data set” for their submission. PLOS defines the minimal data set to consist of the data required to replicate all study findings reported in the article, as well as related metadata and methods (https://journals.plos.org/plosone/s/data-availability#loc-minimal-data-set-definition).

For example, authors should submit the following data:

- The values behind the means, standard deviations and other measures reported;

- The values used to build graphs;

- The points extracted from images for analysis..

Authors do not need to submit their entire data set if only a portion of the data was used in the reported study.

If your submission does not contain these data, please either upload them as Supporting Information files or deposit them to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories.

If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. If data are owned by a third party, please indicate how others may request data access.

6) Please ensure that the funders and grant numbers match between the Financial Disclosure field and the Funding Information tab in your submission form. Note that the funders must be provided in the same order in both places as well. State what role the funders took in the study. If the funders had no role in your study, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.".

If you did not receive any funding for this study, please simply state: u201cThe authors received no specific funding for this work.u201d

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: Reimann et al. present a rigorous and quantitative study demonstrating important roles of the class II PI3Kinase in endosomal organelles and cuticular molting. Using the power of genetics, they show that loss-of-function mutations in piki-1 suppress the molting defects of mutants that enlarge early endosomes, likely by decreasing the number and size of early endosomes. They also demonstrate that PI3,4P2 levels are altered in piki-1 mutants, suggesting that PIKI-1 is the major kinase acting on PI4P to generate PI3,4P2. This suggests the model that PI3,4P2 lipids influence early endosome size and number, which is further corroborated by the identification of a PI3,4P2-binding protein with similar genetic interactions to PIKI-1. These findings are a significant starting point for identifying how PI3,4P2 influences endosomal trafficking with players conserved across animals.

The authors started to explore the trafficking mechanism further and find that piki-1 mutations increase the number of tubules containing Golgi-PM-cycling TGN-38 and Atg8-like LGG-1. However, these markers are found on a diverse range of organelles, which makes it challenging to determine the step at which PIKI-1 or PI3,4P2 are likely to act. Their data suggests that the tubules are also likely covered in PIP3 and the authors propose that these are early endosomal tubules, but the nature and dynamics of the tubules are unclear due to the absence of two-color or time-lapse imaging. The tubulation findings identify a number of informative avenues to pursue in later research and expose gaping holes in our current knowledge of membrane trafficking, but are difficult to synthesize into a mechanistic model at this point.

Major comments

Line 194 - Do the authors think the premature stop codons in piki-1 are likely to cause nonsense-mediated decay or truncate the C2B domain? NMD could be tested experimentally by checking piki-1 mRNA levels, performing a PIKI-1 western (assuming antibodies exist), or suppressing NMD in their triple mutant strain. Also, it would be helpful to briefly comment on what the C2B domain is thought to do. That could help illuminate which subset of PIKI-1 functions are likely to contribute to nekl rescue.

Line 235 - Given the challenges in making PIKI-1 FP knock-ins with consistent localization patterns, do the authors know if any of their tagged PIKI-1s are functional? Does the mScarlet knock-in suppress nekl-2(-); nekl-3(-) defects like the other loss-of-function alleles? Does PIKI-1::mNG expression in hyp7 reinstate the growth phenotype in nekl-2(-); nekl-3(-); piki-1(-)? Also, could the authors comment on whether the hyp7 promoter is likely to cause PIKI-1 overexpression by comparing published levels of endogenous semo-1 and piki-1 mRNA in the hypodermis?

Line 366 - To demonstrate a direct role for PIKI-1 in early steps of autophagy, it would be necessary to show significant colocalization of PIKI-1 and LGG-1. This can be rephrased or addressed experimentally. Also, could the LGG-1+ tubules be a sign of CASM rather than autophagosomes? Testing that would require a fair amount of EM tomography to observe whether any tubular structures have single or double membranes. For this study, it may be better to give more open-ended interpretations.

Line 506 - Given that PIKI-1 is predicted to phosphorylate PI4P, piki-1 mutants may be predicted to have higher levels of PI4P (especially given the observed absence of an increase in PI4,5P2). Have the authors created any PI4P reporters, such as using the P4C domain of SidC? The authors should discuss the possibility that phenotypes could arise from altering PI4P turnover in addition to PI3,4P2 levels. Overexpressing a PI3,4P2 phosphatase or the PI5Kinase required to make PIP3 could also help distinguish between the roles of the different lipids.

A major challenge in studying trafficking is its cyclical nature, where it is difficult to tell if an increased number of tubules in a static image is due to increased formation of tubules or decreased vesicle release from tubules (longer-lived tubules). Can the author’s design any experiments to distinguish between increased tubulation and stalled tubules, i.e. time-lapse imaging or disrupting tubulation factors? Furthermore, comparing tubulation markers would be helpful to distinguish whether the tubulation of multiple organelles is altered or whether everything is likely to be happening on a Rab5+ early endosome.

Minor comments

Line 65 - PIP2 should be bisphosphate, not bi

Line 86 - “via PI(4,5)P2” may be getting into too much detail when introducing the formation of PI3,4P2 by class II PI3Ks. If the authors want to introduce PI4,5P2 conversion to PI4P, that would need a separate sentence, but it could also be omitted here for clarity on PI3Ks.

Fig. 1B - This diagram is very helpful, but would it be possible to move the PI & PI4P entries up to make it clear that Class II PI3Ks are not phosphorylating PI to PI4P? Especially after B&W printing, the green color code will be lost to the reader. With both class II and class III PI3Ks on the same arrow, it gets crowded if the vertical spacing is left symmetric as shown.

Line 165 - Missing a period before “The”

Line 196 - Can the authors speculate on why the S211N mutation would disrupt PIKI-1 function? Is it conserved among this class of PI3Kinases? Otherwise, it would be helpful to highlight in the text that it is in an uncharacterized domain if there is no published supporting data.

Line 277 - Localization is not equivalent to function, so the conclusion about localization data should be toned down to reflect similar localization between worms and mammals. These data raise the possibility that the function is also conserved, but “suggests the role is conserved” sounds too strong. Also, it would be helpful to add a sentence emphasizing that your data suggests PIKI-1 also localizes to unidentified discrete structures that are CLIC-1-negative and RAB-5-negative. These could be the LGG-1+ structures.

Line 290 - “only slightly altered” is vague. Could the authors describe more specifically what they observed?

Fig. 3A - Autophagosomes have double membranes, but the diagram shows a single membrane associated with LGG-1. Atg8 family proteins can also be conjugated to single membranes, aka CASM, LANDO, or LAP. Which do the authors think they are observing?

Fig. 3 Legend - lines 299 & 304 - RAB-7 is missing the FP used, presumably GFP::RAB-7.

Line 349 - It would be helpful to better distinguish between the Golgi markers when introducing AMAN-2, for example referencing what is known about the sub-Golgi localization of alpha-mannosidase II in mammalian cells and emphasizing that AMAN-2 is a Golgi resident protein. It would also be helpful to comment on the lack of AMAN-2+ tubules in piki-1 mutants to better contrast with the TGN-38 findings.

Fig. 4 - Do the authors think that piki-1 is specifically suppressing nekl-2 defects and not nekl-3 defects? The authors interpret these results in terms of organelle specificity, but is it possible to test suppression of individual Nekl phenotypes beyond organelle size?

Line 469 - missing 2 on PI3,4P2.

Line 481 - which movie?

Fig. 5 - Are PI4P or PI3,4P2 levels altered in nekl-2 or nekl-3 mutants?

Line 536-537 - provide full names for SESTD1 & HIP1 for better context

Line 538 - It’s important to repeat the caveat on RNAi when interpreting the negative result with F55D12.2 and contrasting it with hipr-1 RNAi. Otherwise, it gives the impression that F55D12.2 has been ruled out.

Line 565 - Given the AKT-PH tubules in piki-1 mutants, isn’t it more likely that either/both PI3,4P2 and PIP3 are enriched on tubules?

Reviewer #2: General Assessment

This study uses a forward genetic screen in C. elegans to reveal that loss-of-function mutations in piki-1, which encodes the class II PI3K PIKI-1, suppress molting defects associated with NEKL kinases. The authors identify PIKI-1 as a primary regulator of PI(3,4)P₂ in the epidermis and demonstrate that it controls endocytic trafficking by influencing early endosome morphology and protein recruitment. The work is founded on a strong experimental design, and the conclusions are generally well-supported by the data.

However, the manuscript's impact could be significantly enhanced with a more rigorous investigation of the underlying mechanisms, the inclusion of more quantitative analytical methods, and greater clarity in the presentation. The following revisions are recommended to strengthen the manuscript's claims.

Major Comments

1. The manuscript suggests that Class I PI3K is not involved in generating the relevant PI(3,4)P₂ pool. While the data are consistent with PIKI-1 being the primary source, the evidence presented may not be sufficient to definitively exclude any role for Class I PI3K. I recommend moderating this conclusion

2. Defining the Subcellular Localization of PIKI-1: The study localizes PIKI-1 to RAB-5/CLIC-1-positive early endosomes. However, relying on morphology and colocalization with only early endosome markers is insufficient to rule out its presence in other compartments, especially given the resolution of confocal microscopy. To more precisely define PIKI-1's site of action, I recommend expanding the colocalization analysis to markers for other key organelles in the endo-lysosomal pathway, such as: Late endosomes, Recycling endosomes, Lysosomes. This will provide a more comprehensive map of PIKI-1's localization and strengthen the claims about its specific role in early endocytic events.

3. A central conclusion is that piki-1 mutations impair the enzyme's phosphotransferase activity, leading to reduced PI(3,4)P₂. The current evidence is based on genetic suppression, which is indirect. The observed phenotypes in the truncated and missense mutants could result from protein instability rather than a specific defect in catalysis.

4. The study establishes a clear genetic relationship between PIKI-1 and NEKL, but the molecular nature of this interaction remains unclear. Is there any physical interaction between PIKI-1 and NEKL? Assess whether loss of piki-1 affects NEKL kinase activity or localization, which would help position the two proteins relative to one another in the signaling pathway.

5. The hypothesis that PI(3,4)P₂ reduction suppresses nekl defects via the effector protein HIPR-1 is compelling but requires more direct evidence. The logical chain connecting PIKI-1, PI(3,4)P₂, and HIPR-1 is currently incomplete.

Minors

1. Logical Flow & Focus: The transition to Class II PI3Ks (line 83) feels abrupt. Please add a sentence to frame why this class is understudied. I also suggest condensing the descriptions of Class I/III PI3Ks to expand on the known roles and open questions regarding Class II PI3Ks, better highlighting the novelty of your work.

Rationale: Please explicitly state the rationale for focusing on PIKI-1.

2, Citations issues

(Lines 82-87): For the role of PI(3,4)P₂ in endocytic recycling, please cite more direct evidence, such as Roman-Fernandez et al. (ref 51).

(Lines 67-71): If available, add key foundational references regarding PI(4,5)P₂'s role in clathrin-mediated endocytosis.

3. (Line 326): The data show changes in endosome morphology, not function. Rephrasing "role in the function of early endosomes" to "role in the biogenesis or homeostasis of early endosomes" would be more accurate.

(Line 335): The term "only a minor or indirect role" is too definitive. Removing "only" creates a more appropriately cautious statement.

(Line 291): Remove "largely" for a more direct statement.

(Line 363-364): The phrase "although the effect on LGG-1 was less robust" is an unsupported comparison and should be removed or statistically substantiated.

4. Fig S7: The nNeonGreen signal driven by the Phyp7 promoter appears in seam cells. Please clarify if this is expected and whether it might affect colocalization analysis.

5. Please standardize the font sizes of labels within figures for consistency and a more professional appearance (e.g., Fig 3 H, I, L, M; Fig S3 A-F).

6. Please add the full strain names, in addition to allele names to ensure reproducibility.

Reviewer #3: Summary:

Two conserved NIMA127 related Ser/Thr protein kinases, NEKL-2 (NEK8/9 in mammals) and NEKL-3 (NEK6/7), and a number of their binding partners, are essential for proper molting via the regulation of endocytic trafficking. In nekl-2; nekl-3 double mutants, molting is arrested. These mutants suffer 98% larval lethality. Through a well-designed forward genetic screen, the authors isolated a number of extragenic suppressor mutants of the synthetic lethal phenotype. Among the suppressor mutants there are three loss-of-function alleles of piki-1, which encodes the only Class II PI-3 kinase in C. elegans. This manuscript reports the function of PIKI-1 in endocytic recycling in hypodermal cells. The authors found that the primary activity of PIKI-1 is to produce PI(3,4)P2 on the surfaces of early endosomes. Consistent with this activity, PIKI-1 is localized to clathrin-associated compartments and to early endosomes. In piki-1(lof) mutants, among a number of endocytic-related vesicles, early endosomes are specifically abnormal. Particularly, there are fewer early endosomes, and these endosomes are smaller. There are also other phenotypes related to endosomes, such as the tubulation phenotype. Regarding the functional relationship between PIKI-1 and NEKL-2/-3, the suppression of the lethal phenotype displayed by the nekl-2; nekl-3 double mutants by the lof mutations of piki-1 indicates that PIKI-1 acts downstream of NEKL-2 and NEKL-3 and antagonizes their functions. In support of this conclusion, piki-1 mutations appear to suppress the early endosome number and morphological defects displayed by nekl-2 mutants (yet this reviewer has some questions regarding the impact of the opposite early endosome defects displayed by piki-1 and nekl-2 single mutants (see below – Major Concerns)). Furthermore, inactivation of HIPR-1, a potential PI(3,4)P2-binding protein, partially suppresses the larval lethality of the nekl-2; nekl-3 double mutants. This result support the model that “reduced levels of PI(3,4)P2 on early endosomes, along with an accompanying reduction of PI(3,4)P2-binding proteins such as HIPR-1, lead to the suppression of nekl-2; nekl-3 molting defects and to the partial restoration of trafficking functions”.

Evaluation:

This manuscript reveals, for the first time, the potential function of PI(3,4)P2 in an essetial developmental process. It also reveals that the primary function of PIKI-1 is to produce PI(3,4)P2 on early endosomes. Unlike Classes I and III PI-3 kinases, Class II PI-3 kinases are not as well characterized. Class II PI-3 kinases are implicated in vesicle trafficking, cell signaling, and cell migration events. C. elegans PIKI-1 is known to facilitate the degradation of engulfed apoptotic cells confined inside phagosomes by producing PI(3)P in addition to Class III PI-3 kinase VPS-34. The report that PIKI-1’s function in early endosomes by the authors further discovers additional functions of PIKI-1 in cellular functions. The suppression of nekl-2; -3 double mutants further discloses the function of PIKI-1 in development. These novel discoveries should be shared with researchers studying phospholipid, intracellular trafficking, cell signaling, and animal development. This manuscript will be interested by a broad audience. That said, there are a few weak or unclear aspects that needs clarification and/or improvement. These aspects are described below.

Major concerns:

1. The molecular mechanisms behind the functional relationship between the NIMA127 related Ser/Thr protein kinases NEKL-2 and -3 and PI-3 kinase PIKI-1:

The suppression effects of PIKI-1 strongly suggest that NEKL-2/-3 act to inhibit the activity of PIKI-1. what is the molecular mechanism behind this inhibitory effect? This is a challenging question and there are many aspects to explore. For one of those aspects, which is to determine whether this inhibitory functions of the NEKL proteins targets PI(3,4)P2 on early endosomes, the authors should test:

(1) in nekl-2/-3 mutants, whether the level of PI(3,4)P2 increases on early endosomes.

If NEKL-2/-3 act as inhibitors of the PI-3 kinase activity of PIKI-1, one would expect that inactivating these upstream inhibitors will result in more PIKI-1 products (PI(3,4)P2) on early endosomes.

(2) whether HIPR-1 binds PI(3,4)P2.

HIPR-1 is a proposed PI(3,4)P2-binding protein. However, whether this is the case has not been tested. The HIPR-1/PI(3,4)P2 binding ability needs to be tested in vitro and/or in vivo, in order to determine whether the proposed model is correct.

2. How are the defects in the morphology and amount of early endosomes related to the developmental defects.

-- In piki-1(lof) mutants, the authors report that early endosomes are smaller and fewer in number than wild-type. In nekl-2(-) mutants, the authors have observed that early endosomes are bigger and more in number than wild-type, and the early endosomal report displays a brighter intensity. Some clarification is needed as to which (or both) of the opposite phenotypes displayed by the piki-1(-) and nekl-2(-) single mutants will impair the efficiency of endosomal trafficking. Does the presence of larger and more early endosomes indicate an arrest of the proper processing of early endosomes? Does the reduction of early endosome size and number indicate a reduction of early endosome biogenesis? The impacts of these anormalies have not been discussed. Also, it seems that, although piki-1(-) suppresses both the endosomal morphology and amount defects and the larval lethality, this report still has not firmly established that early endosomal defects is the cause for the molting defect of the nekl-2; -3 mutants. The authors need to discuss these issues and other possible models.

3. The molting defect occurs during larval development, yet the characterization of PIKI-1 subcellular localization and the effect of the piki-1 mutations in the signal intensity of a number of fluorescent reporters were performed in one-day old adults. What are the results of the cell biological assays in larval stages? Are they the same as what have been observed in adults?

Specific concern:

Discussion, lines 590-594:

“Previous studies in C. elegans embryos and in the adult gonad indicate that PIKI-1 has a primary role in autophagy in these contexts [72,74–76]. For example, PI(3)P production, which controls autophagy in the C. elegans embryo, is dependent on the coordination among PIKI-1, VPS-34, and MTM-1 (a 3-phosphatase). In addition, loss of PIKI-1 in the embryo and in the gonad strongly impairs autophagosome clearance [76]”.

--None of references 72, 74, 75, 76 indicates that PIKI-1 plays a primary role in autophagy. Specifically, reference 76 reports that loss of PIKI-1 function strongly impairs the clearance of phagosomes that contain apoptotic cells, not autophagosomes. The authors seem to mix up autophagosomes, which are ER-originated intracellular organelles, with phagosomes, which are a vacuole produced by engulfment.

**********

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy , and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

Figure resubmission:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. If there are other versions of figure files still present in your submission file inventory at resubmission, please replace them with the PACE-processed versions.

Reproducibility:

To enhance the reproducibility of your results, we recommend that authors deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Decision Letter 1

Pablo Wappner

6 Feb 2026

Dear Dr Fay,

We are pleased to inform you that your manuscript entitled "PIKI-1, a class II PI 3-kinase, functions in endocytic trafficking" has been editorially accepted for publication in PLOS Genetics. Congratulations!

Before your submission can be formally accepted and sent to production you will need to complete our formatting changes, which you will receive in a follow up email. Please be aware that it may take several days for you to receive this email; during this time no action is required by you. Please note: the accept date on your published article will reflect the date of this provisional acceptance, but your manuscript will not be scheduled for publication until the required changes have been made.

Once your paper is formally accepted, an uncorrected proof of your manuscript will be published online ahead of the final version, unless you’ve already opted out via the online submission form. If, for any reason, you do not want an earlier version of your manuscript published online or are unsure if you have already indicated as such, please let the journal staff know immediately at plosgenetics@plos.org.

In the meantime, please log into Editorial Manager at https://www.editorialmanager.com/pgenetics/, click the "Update My Information" link at the top of the page, and update your user information to ensure an efficient production and billing process. Note that PLOS requires an ORCID iD for all corresponding authors. Therefore, please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field.  This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager.

If you have a press-related query, or would like to know about making your underlying data available (as you will be aware, this is required for publication), please see the end of this email. If your institution or institutions have a press office, please notify them about your upcoming article at this point, to enable them to help maximise its impact. Inform journal staff as soon as possible if you are preparing a press release for your article and need a publication date.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Genetics!

Yours sincerely,

Nathalie Pujol

Academic Editor

PLOS Genetics

Nathalie Pujol

Academic Editor

PLOS Genetics

Aimée Dudley

Editor-in-Chief

PLOS Genetics

Anne Goriely

Editor-in-Chief

PLOS Genetics

www.plosgenetics.org

BlueSky: @plos.bsky.social

----------------------------------------------------

Comments from the reviewers (if applicable):

The authors should carfully review Figure S9B&C

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: The authors have significantly improved the manuscript and include exciting new data that supports their hypotheses, such as a catalytically inactive piki-1 mutant.

The addition of SNX-1 localization is impactful, but underdiscussed. I think Fig. S7 should be added to a main figure. SNX-1 is associated with recycling tubules and retromer trafficking, but these are not discussed in the manuscript. The increase in SNX-1 labeling is consistent with the author’s observations of a shift in sorting endosome domain identity and increased tubules (although the dramatic TGN-38/LGG-1/AKT PH tubules remain mysterious).

The helpful diagram in Fig. 3A also needs SNX-1 added to a sorting endosome tubule.

Fig. S7A, Scarlet is misspelled

Reviewer #3: The authors addressed all of my concerns by explanation and discussion. In a particular case, although the authors did not perform experiments to examine whether the level of PI(3,4)P2 increases on early endosomes, which is expected if NEKL-2/-3 act as inhibitors of the PI-3 kinase activity of PIKI-1, the authors did explain the time constrain. They also provided new experimental evidence indicating that the NEKL-2 and PIKI-1 might directly or indirectly interact in a protein complex. I am thus satisfied by the authors revision.

**********

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy , and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer #1: Yes

Reviewer #3: Yes

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #1: No

Reviewer #3: No

----------------------------------------------------

Data Deposition

If you have submitted a Research Article or Front Matter that has associated data that are not suitable for deposition in a subject-specific public repository (such as GenBank or ArrayExpress), one way to make that data available is to deposit it in the Dryad Digital Repository . As you may recall, we ask all authors to agree to make data available; this is one way to achieve that. A full list of recommended repositories can be found on our website .

The following link will take you to the Dryad record for your article, so you won't have to re‐enter its bibliographic information, and can upload your files directly:

http://datadryad.org/submit?journalID=pgenetics&manu=PGENETICS-D-25-00615R1

More information about depositing data in Dryad is available at http://www.datadryad.org/depositing. If you experience any difficulties in submitting your data, please contact help@datadryad.org for support.

Additionally, please be aware that our data availability policy  requires that all numerical data underlying display items are included with the submission, and you will need to provide this before we can formally accept your manuscript, if not already present.

----------------------------------------------------

Press Queries

If you or your institution will be preparing press materials for this manuscript, or if you need to know your paper's publication date for media purposes, please inform the journal staff as soon as possible so that your submission can be scheduled accordingly. Your manuscript will remain under a strict press embargo until the publication date and time. This means an early version of your manuscript will not be published ahead of your final version. PLOS Genetics may also choose to issue a press release for your article. If there's anything the journal should know or you'd like more information, please get in touch via plosgenetics@plos.org .

Acceptance letter

Pablo Wappner

PGENETICS-D-25-00615R1

PIKI-1, a class II PI 3-kinase, functions in endocytic trafficking

Dear Dr Fay,

We are pleased to inform you that your manuscript entitled "PIKI-1, a class II PI 3-kinase, functions in endocytic trafficking" has been formally accepted for publication in PLOS Genetics! Your manuscript is now with our production department and you will be notified of the publication date in due course.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript.

Soon after your final files are uploaded, unless you have opted out or your manuscript is a front-matter piece, the early version of your manuscript will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

For Research Articles, you will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

Thank you again for supporting PLOS Genetics and open-access publishing. We are looking forward to publishing your work!

With kind regards,

Anita Estes

PLOS Genetics

On behalf of:

The PLOS Genetics Team

Carlyle House, Carlyle Road, Cambridge CB4 3DN | United Kingdom

plosgenetics@plos.org | +44 (0) 1223-442823

plosgenetics.org | Twitter: @PLOSGenetics

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. RNAi of additional PPI modifiers.

    (A) The proportion of viable progeny produced by nekl-2(fd81); nekl-3(gk894345) worms after injection by the indicated dsRNAs. (B) The proportion of viable progeny produced by nekl-2(fd81); nekl-3(gk894345) worms for the indicated genotype. Statistical significance was determined using Fischer’s exact test; ****p ≤ 0.0001, ***p ≤ 0.001. Error bars indicate and 95% CI. Raw data available in this File.

    (TIFF)

    pgen.1011740.s001.tiff (3.3MB, tiff)
    S2 Fig. Endogenous CRISRP-Cas9 PIKI-1 expression.

    (A, B) Representative confocal images of day-1 adults expressing CRISPR-tagged (A) PIKI-1::GFP and (B) PIKI-1::mScarlet. Note that accumulations present in the PIKI-1::mScarlet strain are likely the result of cleavage of mScarlet and its retention in lysosomes.

    (TIFF)

    pgen.1011740.s002.tiff (2.9MB, tiff)
    S3 Fig. PIKI-1 does not colocalize with late endosomes or lysosomes.

    (A–C’ and F–H’) Colocalization of young adult worms expressing Phyp7::PIKI-1::mNeonGreen with (A–C’) GFP::RAB-7 and (F–H’) NUC-1::mCherry. Yellow squares correspond to enlarged insets; yellow arrows indicate examples of colocalization (white). The seam cell is labeled in lower-magnification images. Colocalization was quantified using Mander’s overlap (D, I) and Pearson’s correlation coefficients (E, J). Dot plots show the mean and 95% CI. Statistical significance between rotated and inset values was determined using unpaired t-tests; ns, not significant. Raw data are available in S1 File.

    (TIFF)

    pgen.1011740.s003.tiff (15.9MB, tiff)
    S4 Fig. PIKI-1 does not colocalize with two recycling compartment markers.

    (A–C’ and F–H’) Colocalization of young adult worms expressing heterozygous Phyp7::PIKI-1::mNeonGreen with (A–C’) heterozygous Phyp7::mScarlet::RME-1 (n = 24) or (F–H’) heterozygous CHAT-1::mKate (n = 20). Yellow squares correspond to the enlarged insets; yellow arrows indicate examples of colocalization (white). The seam cell is labeled in A–C and F–H. Colocalization was quantified using Mander’s overlap (D, I) and Pearson’s correlation coefficient (E, J). Dot plots show the mean and 95% CI. Statistical significance between rotated and inset values were determined using unpaired t-tests; ns, not significant. Raw data are available in S1 File.

    (TIFF)

    pgen.1011740.s004.tiff (16.6MB, tiff)
    S5 Fig. Effects of reduction of PIKI-1 function on clathrin and cargos.

    (A, B, D, E, G and H) Representative confocal images of day-1 adults in wild-type and piki-1(Q1507Stop) mutants expressing (A, B) GFP::CHC-1, (D, E) mScarlet::CLIC-1, and (G, H) Phyp7::LRP-1::GFP. The seam cell is labeled in all images. (C, F, and I) Mean intensities corresponding to markers shown in the left-hand panels; (J) Mean intensity for TGN-38::GFP in wild-type and piki-1(Q1507Stop) mutants (also see Fig 3M and 3N). Dot plots show the mean and 95% CI. Statistical significance was determined using unpaired t-tests; *p ≤ 0.05; ns, not significant. Raw data are available in S1 File.

    (TIFF)

    pgen.1011740.s005.tiff (11.2MB, tiff)
    S6 Fig. Effects of reduction of PIKI-1 function on additional endocytic compartments.

    (A, B, E, F, I, J, M and N) Representative confocal images of day-1 adults in wild-type and piki-1(Q1507Stop) mutants expressing (A, B) GFP::RAB-7, (E, F) Phyp7::GFP::RAB-11, (I, J) Phyp7::mNeonGreen::RME-1, (M, N) Phyp7::mNeonGreen::LGG-1. The seam cell is labeled in all images. Red arrows (N) indicate instances of tubulation. (C–P) Indicated parameters corresponding to the left-hand panels are indicated. Dot plots show the mean and 95% CI. Statistical significance (C–O) was determined by an unpaired t-test or (P) Fisher’s exact test. ****p ≤ 0.0001; **p ≤ 0.01; ns, not significant. Raw data are available in S1 File.

    (TIFF)

    pgen.1011740.s006.tiff (15.7MB, tiff)
    S7 Fig. Effects of piki-1(ok2346) deletion allele on PI(3)P and PI(4,5)P2.

    (A) Enlarged image of RAB-5::mKate and 2xTAPP-1::mNeonGreen [PI(3,4)P2] markers showing protrusions and tubule-like structures (green) emanating from early endosomes (magenta). (B, C, E and F) Representative confocal images of wild-type and piki-1(ok2346) day-1 adults expressing (A, B) a PI(3)P lipid sensor [Phyp7::2xFYVE::mNeonGreen] and (D, E) a PI(4,5)P2 lipid sensor [Phyp7::PH PLC δ::mNeonGreen]. (D) Puncta per unit area for worms expressing Phyp7::2xFYVE::mNeonGreen were slightly decreased. (G) Mean intensity for worms expressing Phyp7::PH PLC δ::mNeonGreen was unchanged. Dot plots show the mean and 95% CI. Statistical significance was determined using unpaired t-tests; ****p ≤ 0.0001; ns, not significant. Raw data are available in S1 File.

    (TIFF)

    pgen.1011740.s007.tiff (20.9MB, tiff)
    S8 Fig. Effects of PIKI-1 reduction of function on the multi-specific lipid sensor AKT-PH.

    (A–C, E and F) Representative confocal images of day-1 adults expressing the PI(3,4)P2/PI(3,4,5)P3 lipid sensor Phyp7::AKT::oxGFP in (A) wild-type, (B and C) piki-1(Q1507Stop), or (E and F) piki-1(ok2346) backgrounds. White arrows (A) indicate nuclei. Orange arrows (B, E) indicate aggregations. Red arrows (C, F) indicate tubulations. (D, G) Individual worms expressing Phyp7::AKT-PH::oxGFP were scored for the presence of diffuse labeling, aggregations, or aggregations and tubulations within the epidermis. Statistical significance of the differences in phenotype distributions were determined using Chi-squared tests; ****p < 0.0001. Raw data are available in S1 File.

    (TIFF)

    pgen.1011740.s008.tiff (20.9MB, tiff)
    S9 Fig. Effects of reduction of PIKI-1 function on lysosomal markers.

    (A, B, D and E) Representative confocal images of day-1 adults expressing (A, B) Phyp7::LMP-1::mNeonGreen or (D, E) NUC-1::mCherry in (A, D) wild-type and (B, E) piki-1(Q1507Stop) backgrounds. (C) Mean intensity was plotted for Phyp7::LMP-1::mNeonGreen. (F) The number of puncta per unit area and (G) size of puncta were plotted for NUC-1::mCherry. Dot plots show the mean and 95% CI. Statistical significance was determined using unpaired t-tests; ****p ≤ 0.0001; ns, not significant. Raw data are available in S1 File.

    (TIFF)

    pgen.1011740.s009.tiff (20.9MB, tiff)
    S10 Fig. Marker expression in worms homozygous for Phyp7::PIKI-1::mNeonGreen and Pdyp-7::mKate2::RAB-5.

    (A–C) Representative raw images of a day-1 adult homozygous for both Phyp7::PIKI-1::mNeonGreen and Pdpy-7::mKate2::RAB-5. Both (A,B) single-channel and (C) merged images are shown. Note abnormal expression of PIKI-1 in the seam cell.

    (TIFF)

    pgen.1011740.s010.tiff (20.9MB, tiff)
    S1 Movie. Pnekl-3::2xTAPP1::mNeonGreen in the epidermis of a wild-type worm.

    z-Stack movie showing the expression of the PI(3,4)P2 sensor Pnekl-3::2xTAPP1::mNeonGreen from the apical to the basal plane in the epidermis of a wild-type worm.

    (AVI)

    Download video file (4.5MB, avi)
    S2 Movie. Pnekl-3::2xTAPP1::mNeonGreen in the epidermis of a piki-1(Q1507Stop) worm.

    z-Stack movie showing the expression of the PI(3,4)P2 sensor Pnekl-3::2xTAPP1::mNeonGreen from the apical to the basal plane in the epidermis of a piki-1(Q1507Stop) mutant.

    (AVI)

    Download video file (4.4MB, avi)
    S1 File. Raw data for manuscripts figures.

    Excel file with individual labeled tabs containing raw data for Figs 1–7, S1, and S3–S9. Data are labeled according to figure numbers and panels.

    (XLSX)

    pgen.1011740.s013.xlsx (138.6KB, xlsx)
    S2 File. Supplemental Tables A-C.

    Excel file with individual labeled tabs for Table A, strain list; Table B, RNAi sequences/reagents; and Table C, CRISPR sequences/reagents.

    (XLSX)

    pgen.1011740.s014.xlsx (15.7KB, xlsx)
    Attachment

    Submitted filename: Reimann_Respose_to_reviewers.pdf

    pgen.1011740.s016.pdf (135.6KB, pdf)

    Data Availability Statement

    All relevant data are in the manuscript and its supporting information files.


    Articles from PLOS Genetics are provided here courtesy of PLOS

    RESOURCES